Ingredient ID 10 
Chinese Pronunciation SANKEZHEN 
English Name Wintergreen Barberry Root Or Stem  
Latin Name Radix Seu Caulis Berberidis  
Aliases TongZhenCi
Cancers Colon
Identified Compounds

order by ID

1. Berbamine

   C37H40N2O6   608.73
NSC# 93135 Activity (<10uM)
NSC# 105131 Activity (<10uM)
NSC# 645315 Activity (<10uM)

2. Berberine

   C20H18NO4   336.37
NSC# 150446 Activity (<10uM)
NSC# 163088 Activity (<10uM)

3. Columbamine

   C20H21NO5   355.38

4. Escholine

   C20H24NO4   342.41

5. Isotetrandrine

   C38H42N2O6   622.76
NSC# 77037 Activity (<1uM)
NSC# 91771 Activity (but inactive >10uM)
NSC# 97338 Activity (<10uM)
NSC# 105130 Activity (<10uM)

6. Neprotin

   C20H20NO4   338.38
NSC# 93137 Activity (but inactive >10uM)

7. Oxyacomthine


8. Palmatine

   C21H22NO4   352.41
NSC# 209407 Activity (but inactive >10uM)

Recipes that contain
  1. 286      LiangGenTang
  2. 286      LiangGenTang

Available references (order by impact factor):

1:  Kielman MF, Rindapaa M, Gaspar C, Van Poppel N, Breukel C, Van Leeuwen S, Taketo MM, Roberts S, Smits R, Fodde R.
Corrigendum: Apc modulates embryonic stem-cell differentiation by controlling the dosage of beta-catenin signaling.
Nat Genet.    impact factor:   30.693
2003;  33(1): 107

2:  Seidel-Rogol BL, McCulloch V, Shadel GS.
Human mitochondrial transcription factor B1 methylates ribosomal RNA at a conserved stem-loop.
Nat Genet.    impact factor:   30.693
2003;  33(1): 23-4

3:  Check E.
Biologists seek blueprint for international stem-cell effort.
Nature.    impact factor:   29.491
2003;  421(6919): 102

4:  DeWitt N.
On the road to California.
Nature.    impact factor:   29.491
2002;  420(6916 Suppl): A9

5:  Check E.
Stanford announces private plan to get stem-cell research moving.
Nature.    impact factor:   29.491
2002;  420(6917): 721

6:  Pearson H.
Stem cells: Articles of faith adulterated.
Nature.    impact factor:   29.491
2002;  420(6917): 734-5

7:  Bernardi R, Pandolfi PP.
The nucleolus: at the stem of immortality.
Nat Med.    impact factor:   26.584
2003;  9(1): 24-5

8:  Joshi CV, Enver T.
Plasticity revisited.
Curr Opin Cell Biol.    impact factor:   25.631
2002;  14(6): 749-55

9:  Hochedlinger K, Jaenisch R.
Nuclear transplantation: lessons from frogs and mice.
Curr Opin Cell Biol.    impact factor:   25.631
2002;  14(6): 741-8

10:  Steghaus-Kovac S.
German science. Stem cell project wins final approval.
Science.    impact factor:   24.595
2003;  299(5603): 31

11:  Holden C.
STEM CELL MEDICINE: Stanford Gets Gift for New Institute.
Science.    impact factor:   24.595
2002;  298(5602): 2307-8

12:  Lehar SM, Bevan MJ.
T cell development in culture.
Immunity.    impact factor:   20.563
2002;  17(6): 689-92

13:  Souabni A, Cobaleda C, Schebesta M, Busslinger M.
Pax5 promotes B lymphopoiesis and blocks T cell development by repressing Notch1.
Immunity.    impact factor:   20.563
2002;  17(6): 781-93

14:  Schmitt TM, Zuniga-Pflucker JC.
Induction of T cell development from hematopoietic progenitor cells by delta-like-1 in vitro.
Immunity.    impact factor:   20.563
2002;  17(6): 749-56

15:  Doetsch F, Petreanu L, Caille I, Garcia-Verdugo JM, Alvarez-Buylla A.
EGF converts transit-amplifying neurogenic precursors in the adult brain into multipotent stem cells.
Neuron.    impact factor:   16.782
2002;  36(6): 1021-34

16:  Lebars I, Yoshizawa S, Stenholm AR, Guittet E, Douthwaite S, Fourmy D.
Structure of 23S rRNA hairpin 35 and its interaction with the tylosin-resistance methyltransferase RlmA(II).
EMBO J.    impact factor:   13.973
2003;  22(2): 183-192

17:  Hari L, Brault V, Kleber M, Lee HY, Ille F, Leimeroth R, Paratore C, Suter U, Kemler R, Sommer L.
Lineage-specific requirements of beta-catenin in neural crest development.
J Cell Biol.    impact factor:   12.88
2002;  159(5): 867-80

18:  Monga SP, Monga HK, Tan X, Mule K, Pediaditakis P, Michalopoulos GK.
beta-catenin antisense studies in embryonic liver cultures: Role in proliferation, apoptosis, and lineage specification.
Gastroenterology.    impact factor:   12.182
2003;  124(1): 202-16

19:  Podesta M, Pitto A, Figari O, Bacigalupo A, Bruzzone S, Guida L, Franco L, De Flora A, Zocchi E.
Cyclic ADP-ribose generation by CD38 improves human hemopoietic stem cell engraftment into NOD/SCID mice.
FASEB J.    impact factor:   11.88
2002;  ;[e-pub ahead of print]  20:  Majka SM, Jackson KA, Kienstra KA, Majesky MW, Goodell MA, Hirschi KK.
Distinct progenitor populations in skeletal muscle are bone marrow derived and exhibit different cell fates during vascular regeneration.
J Clin Invest.    impact factor:   10.921
2003;  111(1): 71-79

21:  Schomburg FM, Bizzell CM, Lee DJ, Zeevaart JA, Amasino RM.
Overexpression of a Novel Class of Gibberellin 2-Oxidases Decreases Gibberellin Levels and Creates Dwarf Plants.
Plant Cell.    impact factor:   10.463
2003;  15(1): 151-163

22:  Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, Klinge H, Schumichen C, Nienaber CA, Freund M, Steinhoff G.
Autologous bone-marrow stem-cell transplantation for myocardial regeneration.
Lancet.    impact factor:   10.197
2003;  361(9351): 45-6

23:  Locatelli F, Rossi G, Balduini C.
Hematopoietic stem-cell transplantation for the bernard-soulier syndrome.
Ann Intern Med.    impact factor:   10.097
2003;  138(1): 79

24:  Kubo F, Takeichi M, Nakagawa S.
Wnt2b controls retinal cell differentiation at the ciliary marginal zone.
Development.    impact factor:   10.088
2003;  130(3): 587-98

25:  Assmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, Grunwald F, Aicher A, Urbich C, Martin H, Hoelzer D, Dimmeler S, Zeiher AM.
Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI).
Circulation.    impact factor:   9.903
2002;  106(24): 3009-17

26:  Losordo DW, Kawamoto A.
Biological revascularization and the interventional molecular cardiologist: bypass for the next generation.
Circulation.    impact factor:   9.903
2002;  106(24): 3002-5

27:  Tateishi S, Niwa H, Miyazaki JI, Fujimoto S, Inoue H, Yamaizumi M.
Enhanced Genomic Instability and Defective Postreplication Repair in RAD18 Knockout Mouse Embryonic Stem Cells.
Mol Cell Biol.    impact factor:   9.866
2003;  23(2): 474-481

28:  Stark JM, Jasin M.
Extensive Loss of Heterozygosity Is Suppressed during Homologous Repair of Chromosomal Breaks.
Mol Cell Biol.    impact factor:   9.866
2003;  23(2): 733-43

29:  Shibata S, Lee JT.
Characterization and quantitation of differential Tsix transcripts: implications for Tsix function.
Hum Mol Genet.    impact factor:   9.359
2003;  12(2): 125-36

30:  Brook FA, Evans EP, Lord CJ, Lyons PA, Rainbow DB, Howlett SK, Wicker LS, Todd JA, Gardner RL.
The Derivation of Highly Germline-Competent Embryonic Stem Cells Containing NOD-Derived Genome.
Diabetes.    impact factor:   9.019
2003;  52(1): 205-8

31:  Beilhack GF, Scheffold YC, Weissman IL, Taylor C, Jerabek L, Burge MJ, Masek MA, Shizuru JA.
Purified allogeneic hematopoietic stem cell transplantation blocks diabetes pathogenesis in NOD mice.
Diabetes.    impact factor:   9.019
2003;  52(1): 59-68

32:  Maric D, Maric I, Chang YH, Barker JL.
Prospective cell sorting of embryonic rat neural stem cells and neuronal and glial progenitors reveals selective effects of basic fibroblast growth factor and epidermal growth factor on self-renewal and differentiation.
J Neurosci.    impact factor:   8.955
2003;  23(1): 240-51

33:  Ciccolini F, Collins TJ, Sudhoelter J, Lipp P, Berridge MJ, Bootman MD.
Local and Global Spontaneous Calcium Events Regulate Neurite Outgrowth and Onset of GABAergic Phenotype during Neural Precursor Differentiation.
J Neurosci.    impact factor:   8.955
2003;  23(1): 103-11

34:  Markowska AL, Savonenko AV.
Effectiveness of estrogen replacement in restoration of cognitive function after long-term estrogen withdrawal in aging rats.
J Neurosci.    impact factor:   8.955
2002;  22(24): 10985-95

35:  Tracy J, Flanders A, Madi S, Natale P, Delvecchio N, Pyrros A, Laskas J.
The Brain's Response to Incidental Intruded Words during Focal Text Processing.
Neuroimage.    impact factor:   8.93
2003;  18(1): 117-26

36:  Kilts CD, Egan G, Gideon DA, Ely TD, Hoffman JM.
Dissociable neural pathways are involved in the recognition of emotion in static and dynamic facial expressions.
Neuroimage.    impact factor:   8.93
2003;  18(1): 156-68

37:  Levitin DJ, Menon V, Schmitt JE, Eliez S, White CD, Glover GH, Kadis J, Korenberg JR, Bellugi U, Reiss AL.
Neural correlates of auditory perception in williams syndrome: an FMRI study.
Neuroimage.    impact factor:   8.93
2003;  18(1): 74-82

38:  Baum C, Duellmann J, Li Z, Fehse B, Meyer J, Williams DA, Von Kalle C.
Side effects of retroviral gene transfer into hematopoietic stem cells.
Blood.    impact factor:   8.782
2003;  ;[e-pub ahead of print]  39:  Aldinucci D, Gattei V.
The role of interleukin-3 and stem cell factor in classical Hodgkin disease.
Blood.    impact factor:   8.782
2003;  101(1): 376

40:  Marodon G, Mouly E, Blair EJ, Frisen C, Lemoine FM, Klatzmann D.
Specific transgene expression in human and mouse CD4+ cells using lentiviral vectors with regulatory sequences from the CD4 gene.
Blood.    impact factor:   8.782
2003;  ;[e-pub ahead of print]  41:  Socie G, Salooja N, Cohen A, Rovelli A, Carreras E, Locasciulli A, Korthof E, Weis J, Levy V, Tichelli A.
Non-malignant late effects after allogeneic stem cell transplantation.
Blood.    impact factor:   8.782
2003;  ;[e-pub ahead of print]  42:  Reca R, Mastellos D, Majka M, Marquez L, Ratajczak J, Franchini S, Glodek A, Honczarenko M, Spruce LA, Janowska-Wieczorek A, Lambris JD, Ratajczak MZ.
Functional receptor for C3a anaphylatoxin is expressed by normal hematopoietic stem/progenitor cells, and C3a enhances their homing-related responses to SDF-1.
Blood.    impact factor:   8.782
2003;  ;[e-pub ahead of print]  43:  Ho AY, Kenyon M, El-Hemaidi I, Devereux S, Pagliuca A, Mufti GJ.
Reduced-intensity allogeneic hematopoietic stem cell transplantation with alemtuzumab conditioning regimens: survival does not plateau until after day 200.
Blood.    impact factor:   8.782
2003;  101(2): 779-80

44:  Krampera M, Glennie S, Dyson J, Scott D, Laylor R, Simpson E, Dazzi F.
Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.
Blood.    impact factor:   8.782
2002;  ;[e-pub ahead of print]  45:  Perez SA, Sotiropoulou PA, Gkika DG, Mahaira LG, Niarchos DK, Gritzapis AD, Kavalakis YG, Antsaklis AI, Baxevanis CN, Papamichail M.
A novel myeloid-like NK cell progenitor in human umbilical cord blood.
Blood.    impact factor:   8.782
2002;  ;[e-pub ahead of print]  46:  Storek J, Viganego F, Dawson MA, Herremans MM, Boeckh M, Flowers ME, Storer B, Bensinger WI, Witherspoon RP, Maloney DG.
Factors affecting antibody levels after allogeneic hematopoietic cell transplantation.
Blood.    impact factor:   8.782
2002;  ;[e-pub ahead of print]  47:  Chagraoui J, Lepage-Noll A, Anjo A, Uzan G, Charbord P.
Fetal liver stroma consists of cells in epithelial-to-mesenchymal transition.
Blood.    impact factor:   8.782
2002;  ;[e-pub ahead of print]  48:  Liu JM, Lawrence F, Kovacevic M, Bignon JS, Papadimitriou E, Lallemand JY, Katsoris P, Potier P, Fromes Y, Wdzieczak-Bakala J.
The tetrapeptide AcSDKP, an inhibitor of primitive hematopoietic cell proliferation, induces angiogenesis in vitro and in vivo.
Blood.    impact factor:   8.782
2002;  ;[e-pub ahead of print]  49:  Yurugi-Kobayashi T, Itoh H, Yamashita J, Yamahara K, Hirai H, Kobayashi T, Ogawa M, Nishikawa S, Nishikawa SI, Nakao K.
Effective contribution of transplanted vascular progenitor cells derived from embryonic stem cells to adult neovascularization in proper differentiation stage.
Blood.    impact factor:   8.782
2002;  ;[e-pub ahead of print]  50:  Devine SM, Cobbs C, Jennings M, Bartholomew A, Hoffman R.
Mesenchymal stem cells distribute to a wide range of tissues following systemic infusion into non-human primates.
Blood.    impact factor:   8.782
2002;  ;[e-pub ahead of print]  51:  Shimazaki C, Ochiai N, Uchida R, Okano A, Fuchida SI, Ashihara E, Inaba T, Fujita N, Maruya E, Nakagawa M.
Non-T-cell depleted HLA haploidentical stem cell transplantation in advanced hematological malignancies based on the feto-maternal microchimerism.
Blood.    impact factor:   8.782
2002;  ;[e-pub ahead of print]  52:  Wang J, Kimura T, Asada R, Harada S, Yokota S, Kawamoto Y, Fujimura Y, Tsuji T, Ikehara S, Sonoda Y.
SCID-repopulating cell activity of human cord blood-derived CD34-negative cells assured by intra-bone marrow injection.
Blood.    impact factor:   8.782
2002;  ;[e-pub ahead of print]  53:  Johnson JJ, Chen W, Hudson W, Yao Q, Taylor M, Rabbitts TH, Kersey JH.
Prenatal and postnatal myeloid cells demonstrate stepwise progression in the pathogenesis of MLL fusion gene leukemia.
Blood.    impact factor:   8.782
2002;  ;[e-pub ahead of print]  54:  Frias S, Van Hummelen P, Meistrich ML, Lowe XR, Hagemeister FB, Shelby MD, Bishop JB, Wyrobek AJ.
NOVP Chemotherapy for Hodgkin's Disease Transiently Induces Sperm Aneuploidies Associated with the Major Clinical Aneuploidy Syndromes Involving Chromosomes X, Y, 18, and 21.
Cancer Res.    impact factor:   8.614
2003;  63(1): 44-51

55:  Ehtesham M, Kabos P, Gutierrez MA, Chung NH, Griffith TS, Black KL, Yu JS.
Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand.
Cancer Res.    impact factor:   8.614
2002;  62(24): 7170-4

56:  Mossink MH, Van Zon A, Franzel-Luiten E, Schoester M, Kickhoefer VA, Scheffer GL, Scheper RJ, Sonneveld P, Wiemer EA.
Disruption of the Murine Major Vault Protein (MVP/LRP) Gene Does Not Induce Hypersensitivity to Cytostatics.
Cancer Res.    impact factor:   8.614
2002;  62(24): 7298-304

57:  Drachman DB, Jones RJ, Brodsky RA.
Treatment of refractory myasthenia: "Rebooting" with high-dose cyclophosphamide.
Ann Neurol.    impact factor:   8.321
2003;  53(1): 29-34

58:  Orlic D, Hill JM, Arai AE.
Stem cells for myocardial regeneration.
Circ Res.    impact factor:   8.281
2002;  91(12): 1092-102

59:  Ringden O, Labopin M, Bacigalupo A, Arcese W, Schaefer UW, Willemze R, Koc H, Bunjes D, Gluckman E, Rocha V, Schattenberg A, Frassoni F.
Transplantation of Peripheral Blood Stem Cells as Compared With Bone Marrow From HLA-Identical Siblings in Adult Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia.
J Clin Oncol.    impact factor:   7.963
2002;  20(24): 4655-64

60:  Fargeas CA, Florek M, Huttner WB, Corbeil D.
Characterization of prominin-2, a new member of the prominin family of pentaspan membrane glycoproteins.
J Biol Chem.    impact factor:   7.666
2003;  ;[e-pub ahead of print]  61:  Yan Z, Choi S, Liu X, Zhang M, Schageman JJ, Lee SY, Hart R, Lin L, Thurmond FA, Williams RS.
Highly coordinated gene regulation in mouse skeletal muscle regeneration.
J Biol Chem.    impact factor:   7.666
2002;  ;[e-pub ahead of print]  62:  Tan BL, Hong L, Munugalavadla V, Kapur R.
Functional and biochemical consequences of abrogating the activation of multiple diverse early signaling pathways in kit: role for Src kinase pathway in kit induced cooperation with Epo-R.
J Biol Chem.    impact factor:   7.666
2002;  ;[e-pub ahead of print]  63:  Gwizdek C, Ossareh-Nazari B, Brownawell AM, Doglio A, Bertrand E, Macara IG, Dargemont C.
Exportin-5 mediates nuclear export of minihelix-containing RNAs.
J Biol Chem.    impact factor:   7.666
2002;  ;[e-pub ahead of print]  64:  Tatton L, Morley GM, Chopra R, Khwaja A.
The Src-selective kinase inhibitor PP1 also inhibits kit and Bcr-Abl tyrosine kinases.
J Biol Chem.    impact factor:   7.666
2002;  ;[e-pub ahead of print]  65:  Morse D, Cermakian N, Brancorsini S, Parvinen M, Sassone-Corsi P.
No Circadian Rhythms in Testis: Period1 Expression Is Clock Independent and Developmentally Regulated in the Mouse.
Mol Endocrinol.    impact factor:   7.566
2003;  17(1): 141-151

66:  Zhou S, Turgeman G, Harris SE, Leitman DC, Komm BS, Bodine PV, Gazit D.
Estrogens activate bone morphogenetic protein-2 gene transcription in mouse mesenchymal stem cells.
Mol Endocrinol.    impact factor:   7.566
2003;  17(1): 56-66

67:  Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H, Alfonso ZC, Fraser JK, Benhaim P, Hedrick MH.
Human adipose tissue is a source of multipotent stem cells.
Mol Biol Cell.    impact factor:   7.527
2002;  13(12): 4279-95

68:  Fiegel HC, Park JJ, Lioznov MV, Martin A, Jaeschke-Melli S, Kaufmann PM, Fehse B, Zander AR, Kluth D.
Characterization of cell types during rat liver development.
Hepatology.    impact factor:   7.344
2003;  37(1): 148-54

69:  Broxmeyer HE, Cooper S, Kohli L, Hangoc G, Lee Y, Mantel C, Clapp DW, Kim CH.
Transgenic expression of stromal cell-derived factor-1/CXC chemokine ligand 12 enhances myeloid progenitor cell survival/antiapoptosis in vitro in response to growth factor withdrawal and enhances myelopoiesis in vivo.
J Immunol.    impact factor:   7.145
2003;  170(1): 421-9

70:  Jones EA, Kinsey SE, English A, Jones RA, Straszynski L, Meredith DM, Markham AF, Jack A, Emery P, McGonagle D.
Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells.
Arthritis Rheum.    impact factor:   7.054
2002;  46(12): 3349-60

71:  Ren R.
The molecular mechanism of chronic myelogenous leukemia and its therapeutic implications: studies in a murine model.
Oncogene.    impact factor:   6.517
2002;  21(56): 8629-42

72:  Cantz T, Zuckerman DM, Burda MR, Dandri M, Goricke B, Thalhammer S, Heckl WM, Manns MP, Petersen J, Ott M.
Quantitative Gene Expression Analysis Reveals Transition of Fetal Liver Progenitor Cells to Mature Hepatocytes after Transplantation in uPA/RAG-2 Mice.
Am J Pathol.    impact factor:   6.436
2003;  162(1): 37-45

73:  Hu J, Takatoku M, Sellers SE, Agricola BA, Metzger ME, Donahue RE, Dunbar CE.
Analysis of origin and optimization of expansion and transduction of circulating peripheral blood endothelial progenitor cells in the rhesus macaque model.
Hum Gene Ther.    impact factor:   6.403
2002;  13(17): 2041-50

74:  Baker KE, Mackie GA.
Ectopic RNase E sites promote bypass of 5'-end-dependent mRNA decay in Escherichia coli.
Mol Microbiol.    impact factor:   6.361
2003;  47(1): 75-88

75:  Wharton KA.
Runnin' with the dvl: proteins that associate with dsh/dvl and their significance to wnt signal transduction.
Dev Biol.    impact factor:   6.049
2003;  253(1): 1-17

76:  Chabregas SM, Luche DD, Van Sluys MA, Menck CF, Silva-Filho MC.
Differential usage of two in-frame translational start codons regulates subcellular localization of Arabidopsis thaliana THI1.
J Cell Sci.    impact factor:   6.044
2003;  116(Pt 2): 285-291

77:  Michaelson JS, Leder P.
RNAi reveals anti-apoptotic and transcriptionally repressive activities of DAXX.
J Cell Sci.    impact factor:   6.044
2003;  116(Pt 2): 345-52

78:  Gowda S, Ayllon MA, Satyanarayana T, Bar-Joseph M, Dawson WO.
Transcription strategy in a Closterovirus: a novel 5'-proximal controller element of Citrus Tristeza Virus produces 5'- and 3'-terminal subgenomic RNAs and differs from 3' open reading frame controller elements.
J Virol.    impact factor:   5.93
2003;  77(1): 340-52

79:  Bartz JC, Kincaid AE, Bessen RA.
Rapid prion neuroinvasion following tongue infection.
J Virol.    impact factor:   5.93
2003;  77(1): 583-91

80:  Musey L, Ding Y, Cao J, Lee J, Galloway C, Yuen A, Jerome KR, McElrath MJ.
Ontogeny and specificities of mucosal and blood human immunodeficiency virus type 1-specific CD8(+) cytotoxic T lymphocytes.
J Virol.    impact factor:   5.93
2003;  77(1): 291-300

81:  Panavas T, Nagy PD.
The RNA replication enhancer element of tombusviruses contains two interchangeable hairpins that are functional during plus-strand synthesis.
J Virol.    impact factor:   5.93
2003;  77(1): 258-69

82:  Ray D, White KA.
An internally located RNA hairpin enhances replication of Tomato bushy stunt virus RNAs.
J Virol.    impact factor:   5.93
2003;  77(1): 245-57

83:  Russell RS, Hu J, Beriault V, Mouland AJ, Kleiman L, Wainberg MA, Liang C.
Sequences downstream of the 5' splice donor site are required for both packaging and dimerization of human immunodeficiency virus type 1 RNA.
J Virol.    impact factor:   5.93
2003;  77(1): 84-96

84:  Stryke D, Kawamoto M, Huang CC, Johns SJ, King LA, Harper CA, Meng EC, Lee RE, Yee A, L'Italien L, Chuang PT, Young SG, Skarnes WC, Babbitt PC, Ferrin TE.
BayGenomics: a resource of insertional mutations in mouse embryonic stem cells.
Nucleic Acids Res.    impact factor:   5.748
2003;  31(1): 278-281

85:  Lee JH, Kim H, Ko J, Lee Y.
Interaction of C5 protein with RNA aptamers selected by SELEX.
Nucleic Acids Res.    impact factor:   5.748
2002;  30(24): 5360-8

86:  Brannvall K, Korhonen L, Lindholm D.
Estrogen-receptor-dependent regulation of neural stem cell proliferation and differentiation.
Mol Cell Neurosci.    impact factor:   5.654
2002;  21(3): 512-20

87:  Mei SH, Liu Z, Brennan JD, Li Y.
An Efficient RNA-Cleaving DNA Enzyme that Synchronizes Catalysis with Fluorescence Signaling.
J Am Chem Soc.    impact factor:   5.537
2003;  125(2): 412-20

88:  Lee JC, Cannone JJ, Gutell RR.
The lonepair triloop: a new motif in RNA structure.
J Mol Biol.    impact factor:   5.501
2003;  325(1): 65-83

89:  Brey RL.
Severe neurologic complications after hematopoietic (peripheral blood) stem cell transplantation in children.
Neurology.    impact factor:   5.232
2002;  59(12): E13-5

90:  Faraci M, Lanino E, Dini G, Fondelli MP, Morreale G, Dallorso S, Manzitti C, Calevo MG, Gaggero R, Castagnola E, Haupt R.
Severe neurologic complications after hematopoietic stem cell transplantation in children.
Neurology.    impact factor:   5.232
2002;  59(12): 1895-904

91:  Gossele V, Fache I, Meulewaeter F, Cornelissen M, Metzlaff M.
SVISS - a novel transient gene silencing system for gene function discovery and validation in tobacco plants.
Plant J.    impact factor:   5.09
2002;  32(5): 859-66

92:  Ender A, Schierwater B.
Placozoa are not derived cnidarians: evidence from molecular morphology.
Mol Biol Evol.    impact factor:   4.983
2003;  20(1): 130-4

93:  Luo Y, Cai J, Liu Y, Xue H, Chrest FJ, Wersto RP, Rao M.
Microarray analysis of selected genes in neural stem and progenitor cells.
J Neurochem.    impact factor:   4.906
2002;  83(6): 1481-97

94:  Ito M, Kizawa K, Toyoda M, Morohashi M.
Label-retaining Cells in the Bulge Region are Directed to Cell Death after Plucking, Followed by Healing from the Surviving Hair Germ.
J Invest Dermatol.    impact factor:   4.903
2002;  119(6): 1310-6

95:  Ikawa Y, Yoshimura T, Hara H, Shiraishi H, Inoue T.
Two conserved structural components, A-rich bulge and P4 XJ6/7 base-triples, in activating the group I ribozymes.
Genes Cells.    impact factor:   4.869
2002;  7(12): 1205-15

96:  Hamprecht K, Eckle T, Prix L, Faul C, Einsele H, Jahn G.
Ganciclovir-Resistant Cytomegalovirus Disease after Allogeneic Stem Cell Transplantation: Pitfalls of Phenotypic Diagnosis by In Vitro Selection of an UL97 Mutant Strain.
J Infect Dis.    impact factor:   4.842
2003;  187(1): 139-43

97:  Sleeper E, Tamm C, Frisen J, Zhivotovsky B, Orrenius S, Ceccatelli S.
Cell death in adult neural stem cells.
Cell Death Differ.    impact factor:   4.733
2002;  9(12): 1377-1378

98:  Ward CM, Stern P, Willington MA, Flenniken AM.
Efficient germline transmission of mouse embryonic stem cells grown in synthetic serum in the absence of a fibroblast feeder layer.
Lab Invest.    impact factor:   4.53
2002;  82(12): 1765-7

99:  Antzutkin ON, Leapman RD, Balbach JJ, Tycko R.
Supramolecular structural constraints on Alzheimer's beta-amyloid fibrils from electron microscopy and solid-state nuclear magnetic resonance.
Biochemistry.    impact factor:   4.493
2002;  41(51): 15436-50

100:  Paoletti AC, Shubsda MF, Hudson BS, Borer PN.
Affinities of the nucleocapsid protein for variants of SL3 RNA in HIV-1.
Biochemistry.    impact factor:   4.493
2002;  41(51): 15423-8

101:  Rist MJ, Marino JP.
Mechanism of Nucleocapsid Protein Catalyzed Structural Isomerization of the Dimerization Initiation Site of HIV-1.
Biochemistry.    impact factor:   4.493
2002;  41(50): 14762-70

102:  Mulichak AM, Bonin CP, Reiter WD, Garavito RM.
Structure of the MUR1 GDP-Mannose 4,6-Dehydratase from Arabidopsis thaliana: Implications for Ligand Binding and Specificity.
Biochemistry.    impact factor:   4.493
2002;  41(52): 15578-89

103:  Kulkarni S, Bessler M.
The effect of GPI-anchor deficiency on apoptosis in mice carrying a Piga gene mutation in hematopoietic cells.
J Leukoc Biol.    impact factor:   4.283
2002;  72(6): 1228-33

104:  Jin YH, Bailey TW, Doyle MW, Li BY, Chang KS, Schild JH, Mendelowitz D, Andresen MC.
Ketamine differentially blocks sensory afferent synaptic transmission in medial nucleus tractus solitarius (mNTS).
Anesthesiology.    impact factor:   4.265
2003;  98(1): 121-32

105:  Rakic S, Zecevic N.
Early oligodendrocyte progenitor cells in the human fetal telencephalon.
Glia.    impact factor:   4.245
2003;  41(2): 117-27

106:  Takatsuka H, Iwasaki T, Okamoto T, Kakishita E.
Intestinal graft-versus-host disease: mechanisms and management.
Drugs.    impact factor:   4.15
2003;  63(1): 1-15

107:  Dale DC.
Colony-stimulating factors for the management of neutropenia in cancer patients.
Drugs.    impact factor:   4.15
2002;  62 Suppl 1: 1-15

108:  Schriber J.
Treatment of aggressive non-Hodgkin's lymphoma with chemotherapy in combination with filgrastim.
Drugs.    impact factor:   4.15
2002;  62 Suppl 1: 33-46

109:  Anderlini P, Champlin R.
Use of filgrastim for stem cell mobilisation and transplantation in high-dose cancer chemotherapy.
Drugs.    impact factor:   4.15
2002;  62 Suppl 1: 79-88

110:  Shen X, Collier JM, Hlaing M, Zhang L, Delshad EH, Bristow J, Bernstein HS.
Genome-wide examination of myoblast cell cycle withdrawal during differentiation.
Dev Dyn.    impact factor:   3.939
2003;  226(1): 128-38

111:  Backman M, Machon O, Van Den Bout CJ, Krauss S.
Targeted disruption of mouse Dach1 results in postnatal lethality.
Dev Dyn.    impact factor:   3.939
2003;  226(1): 139-44

112:  Galloway JL, Zon LI.
Ontogeny of hematopoiesis: examining the emergence of hematopoietic cells in the vertebrate embryo.
Curr Top Dev Biol.    impact factor:   3.914
2003;  53: 139-58

113:  Merino A, Mazzara R, Fuste B, Diaz-Ricart M, Rozman M, Lozano M, Ordinas A.
The mesenchymal stem cell revealed.
Transfusion.    impact factor:   3.77
2003;  43(1): 1

114:  Takeda S, Miyoshi S, Ohta M, Minami M, Masaoka A, Matsuda H.
Primary germ cell tumors in the mediastinum.
Cancer.    impact factor:   3.632
2003;  97(2): 367-76

115:  Wilcox CS, Welch WJ.
Thromboxane synthase and TP receptor mRNA in rat kidney and brain: effects of salt intake and ANG II.
Am J Physiol Renal Physiol.    impact factor:   3.59
2003;  ;[e-pub ahead of print]  116:  Yang D, Cheung P, Sun Y, Yuan J, Zhang H, Carthy CM, Anderson DR, Bohunek L, Wilson JE, McManus BM.
A Shine-Dalgarno-like Sequence Mediates in Vitro Ribosomal Internal Entry and Subsequent Scanning for Translation Initiation of Coxsackievirus B3 RNA.
Virology.    impact factor:   3.548
2003;  305(1): 31-43

117:  Monci F, Sanchez-Campos S, Navas-Castillo J, Moriones E.
A Natural Recombinant between the Geminiviruses Tomato yellow leaf curl Sardinia virus and Tomato yellow leaf curl virus Exhibits a Novel Pathogenic Phenotype and Is Becoming Prevalent in Spanish Populations.
Virology.    impact factor:   3.548
2002;  303(2): 317-26

118:  Russell RS, Hu J, Laughrea M, Wainberg MA, Liang C.
Deficient dimerization of human immunodeficiency virus type 1 RNA caused by mutations of the u5 RNA sequences.
Virology.    impact factor:   3.548
2002;  303(1): 152-63

119:  Baron F, Fillet G, Beguin Y.
Erythropoiesis after nonmyeloablative stem-cell transplantation is not impaired by inadequate erythropoietin production as observed after conventional allogeneic transplantation.
Transplantation.    impact factor:   3.463
2002;  74(12): 1692-6

120:  Novitzky N, Davison GM, Hale G, Waldmann H.
Immune reconstitution at 6 months following T-cell depleted hematopoietic stem cell transplantation is predictive for treatment outcome.
Transplantation.    impact factor:   3.463
2002;  74(11): 1551-9

121:  Dingli D, Timm M, Russell SJ, Witzig TE, Rajkumar SV.
Promising preclinical activity of 2-methoxyestradiol in multiple myeloma.
Clin Cancer Res.    impact factor:   3.442
2002;  8(12): 3948-54

122:  Climent J, Martinez-Climent JA, Blesa D, Garcia-Barchino MJ, Saez R, Sanchez-Izquierdo D, Azagra P, Lluch A, Garcia-Conde J.
Genomic loss of 18p predicts an adverse clinical outcome in patients with high-risk breast cancer.
Clin Cancer Res.    impact factor:   3.442
2002;  8(12): 3863-9

123:  Buehr M, Nichols J, Stenhouse F, Mountford P, Greenhalgh CJ, Kantachuvesiri S, Brooker G, Mullins J, Smith AG.
Rapid Loss of Oct-4 and Pluripotency in Cultured Rodent Blastocysts and Derivative Cell Lines.
Biol Reprod.    impact factor:   3.417
2003;  68(1): 222-229

124:  Ogawa T, Ohmura M, Yumura Y, Sawada H, Kubota Y.
Expansion of murine spermatogonial stem cells through serial transplantation.
Biol Reprod.    impact factor:   3.417
2003;  68(1): 316-22

125:  Izadyar F, Den Ouden K, Creemers LB, Posthuma G, Parvinen M, De Rooij DG.
Proliferation and differentiation of bovine type a spermatogonia during long-term culture.
Biol Reprod.    impact factor:   3.417
2003;  68(1): 272-81

126:  Kanatsu-Shinohara M, Ogonuki N, Inoue K, Ogura A, Toyokuni S, Honjo T, Shinohara T.
Allogeneic offspring produced by male germ line stem cell transplantation into infertile mouse testis.
Biol Reprod.    impact factor:   3.417
2003;  68(1): 167-73

127:  Braak H, Tredici KD, Rub U, de Vos RA, Jansen Steur EN, Braak E.
Staging of brain pathology related to sporadic Parkinson's disease.
Neurobiol Aging.    impact factor:   3.399
2003;  24(2): 197-211

128:  Gerosa M, Nicolato A, Foroni R, Zanotti B, Tomazzoli L, Miscusi M, Alessandrini F, Bricolo A.
Gamma knife radiosurgery for brain metastases: a primary therapeutic option.
J Neurosurg.    impact factor:   3.346
2002;  97(5 Suppl): 515-24

129:  Welinder KG, Justesen AF, Kjaersgard IV, Jensen RB, Rasmussen SK, Jespersen HM, Duroux L.
Structural diversity and transcription of class III peroxidases from Arabidopsis thaliana.
Eur J Biochem.    impact factor:   3.307
2002;  269(24): 6063-6081

130:  Ferland RJ, Williams JP, Gross RA, Applegate CD.
The Effects of Brain-Irradiation-Induced Decreases in Hippocampal Mitotic Activity on Flurothyl-Induced Epileptogenesis in Adult C57BL/6J Mice.
Exp Neurol.    impact factor:   3.26
2003;  179(1): 71-82

131:  Liu PH, Wang YJ, Tseng GF.
Close axonal injury of rubrospinal neurons induced transient perineuronal astrocytic and microglial reaction that coincided with their massive degeneration.
Exp Neurol.    impact factor:   3.26
2003;  179(1): 111-26

132:  Kabos P, Ehtesham M, Kabosova A, Black KL, Yu JS.
Generation of neural progenitor cells from whole adult bone marrow.
Exp Neurol.    impact factor:   3.26
2002;  178(2): 288-93

133:  Fujiki H, Kimura T, Minamiguchi H, Harada S, Wang J, Nakao M, Yokota S, Urata Y, Ueda Y, Yamagishi H, Sonoda Y.
Role of human interleukin-9 as a megakaryocyte potentiator in culture.
Exp Hematol.    impact factor:   3.258
2002;  30(12): 1373-80

134:  Riley RL, Knowles J, King AM.
Levels of E2A protein expression in B cell precursors are stage-dependent and inhibited by stem cell factor (c-kit ligand).
Exp Hematol.    impact factor:   3.258
2002;  30(12): 1412-8

135:  Almeida-Porada G, El Shabrawy D, Porada C, Zanjani ED.
Differentiative potential of human metanephric mesenchymal cells.
Exp Hematol.    impact factor:   3.258
2002;  30(12): 1454-62

136:  Sieburg HB, Cho RH, Muller-Sieburg CE.
Limiting dilution analysis for estimating the frequency of hematopoietic stem cells. Uncertainty and significance.
Exp Hematol.    impact factor:   3.258
2002;  30(12): 1436-43

137:  Miyagi T, Takeno M, Nagafuchi H, Takahashi M, Suzuki N.
Flk1(+) cells derived from mouse embryonic stem cells reconstitute hematopoiesis in vivo in SCID mice.
Exp Hematol.    impact factor:   3.258
2002;  30(12): 1444-53

138:  Peggs KS, Verfuerth S, D'Sa S, Yong K, Mackinnon S.
Assessing diversity: immune reconstitution and T-cell receptor BV spectratype analysis following stem cell transplantation.
Br J Haematol.    impact factor:   3.204
2003;  120(1): 154-65

139:  Chakrabarti S, Avivi I, Mackinnon S, Ward K, Kottaridis PD, Osman H, Waldmann H, Hale G, Fegan CD, Yong K, Goldstone AH, Linch DC, Milligan DW.
Respiratory virus infections in transplant recipients after reduced-intensity conditioning with Campath-1H: high incidence but low mortality.
Br J Haematol.    impact factor:   3.204
2002;  119(4): 1125-32

140:  Nordlander A, Uzunel M, Mattsson J, Remberger M.
The TNFd4 allele is correlated to moderate-to-severe acute graft-versus-host disease after allogeneic stem cell transplantation.
Br J Haematol.    impact factor:   3.204
2002;  119(4): 1133-6

141:  Amo K, Tanaka-Taya K, Inagi R, Miyagawa H, Miyoshi H, Okusu I, Sashihara J, Hara J, Nakayama M, Yamanishi K, Okada S.
Human herpesvirus 6B infection of the large intestine of patients with diarrhea.
Clin Infect Dis.    impact factor:   3.199
2003;  36(1): 120-3

142:  Michael Schopperle W, Kershaw DB, DeWolf WC.
Human embryonal carcinoma tumor antigen, Gp200/GCTM-2, is podocalyxin.
Biochem Biophys Res Commun.    impact factor:   3.161
2003;  300(2): 285-90

143:  Ma T, Kramer RE, Baker RC, Fan LW, Ho IK.
Effects of chronic dermal exposure to nonlethal doses of methyl parathion on brain regional acetylcholinesterase and muscarinic cholinergic receptors in female rats.
J Neurosci Res.    impact factor:   3.126
2003;  71(1): 138-45

144:  Kim D, Im JO, Won YJ, Yoon SY, Lee EJ, Lee JH, Hong HN.
Upregulation of c-Kit receptor and stem cell factor in cerebellar inhibitory synapses in response to kainic acid.
J Neurosci Res.    impact factor:   3.126
2003;  71(1): 72-8

145:  Hong Y, Yu SS, Kim JM, Lee K, Na YS, Whitley CB, Sugimoto Y, Kim S.
Construction of a high efficiency retroviral vector for gene therapy of Hunter's syndrome.
J Gene Med.    impact factor:   3.103
2003;  5(1): 18-29

146:  Eshkind L, Tian Q, Schmidt A, Franke WW, Windoffer R, Leube RE.
Loss of desmoglein 2 suggests essential functions for early embryonic development and proliferation of embryonal stem cells.
Eur J Cell Biol.    impact factor:   3.043
2002;  81(11): 592-8

147:  Veselov D, Langhans M, Hartung W, Aloni R, Feussner I, Gotz C, Veselova S, Schlomski S, Dickler C, Bachmann K, Ullrich CI.
Development of Agrobacterium tumefaciens C58-induced plant tumors and impact on host shoots are controlled by a cascade of jasmonic acid, auxin, cytokinin, ethylene and abscisic acid.
Planta.    impact factor:   2.977
2003;  216(3): 512-22

148:  Lee SC, Hwang BK.
Identification of the pepper SAR8.2 gene as a molecular marker for pathogen infection, abiotic elicitors and environmental stresses in Capsicum annuum.
Planta.    impact factor:   2.977
2003;  216(3): 387-96

149:  Tacheva DM, Vladimirov IK.
Embryos, preembryos, and stem cells.
Fertil Steril.    impact factor:   2.955
2002;  78(6): 1354-5

150:  Thorne R, Kischer CW.
Embryos, preembryos, and stem cells.
Fertil Steril.    impact factor:   2.955
2002;  78(6): 1355

151:  Jones HW, Veeck LL.
Embryos, preembryos, and stem cells: Reply of the authors.
Fertil Steril.    impact factor:   2.955
2002;  78(6): 1355-6

152:  Nagano M, Patrizio P, Brinster RL.
Long-term survival of human spermatogonial stem cells in mouse testes.
Fertil Steril.    impact factor:   2.955
2002;  78(6): 1225-33

153:  Starr JM, Leaper SA, Murray AD, Lemmon HA, Staff RT, Deary IJ, Whalley LJ.
Brain white matter lesions detected by magnetic resosnance imaging are associated with balance and gait speed.
J Neurol Neurosurg Psychiatry.    impact factor:   2.846
2003;  74(1): 94-98

154:  Schuller P, Bruns F, Hesselmann S, Horn K, Panke JE, Schuck A, Schafer U, Micke O, Willich N.
Simulator verification of the accuracy of patient repositioning after virtual simulation is physical simulation still needed?
Strahlenther Onkol.    impact factor:   2.846
2002;  178(12): 715-21

155:  Matthews A, Kirkby KC, Martin F.
The effects of single-dose lorazepam on memory and behavioural learning.
J Psychopharmacol.    impact factor:   2.827
2002;  16(4): 345-54

156:  Solomon A, Espana EM, Tseng SC.
Amniotic membrane transplantation for reconstruction of the conjunctival fornices.
Ophthalmology.    impact factor:   2.725
2003;  110(1): 93-100

157:  Holland EJ, Djalilian AR, Schwartz GS.
Management of aniridic keratopathy with keratolimbal allograft: a limbal stem cell transplantation technique.
Ophthalmology.    impact factor:   2.725
2003;  110(1): 125-30

158:  Kanwal JS, Rao PD.
Oxytocin within auditory nuclei: a neuromodulatory function in sensory processing?
Neuroreport.    impact factor:   2.682
2002;  13(17): 2193-7

159:  Wu L, Nishiyama K, Hollyfield JG, Wang Q.
Localization of Nav1.5 sodium channel protein in the mouse brain.
Neuroreport.    impact factor:   2.682
2002;  13(18): 2547-51

160:  Enomoto A, Kogo M, Koizumi H, Ishihama K, Yamanishi T.
Localization of premotoneurons for an NMDA-induced repetitive rhythmical activity to TMNs.
Neuroreport.    impact factor:   2.682
2002;  13(17): 2303-2307

161:  Lobo MV, Alonso FJ, Redondo C, Lopez-Toledano MA, Caso E, Herranz AS, Paino CL, Reimers D, Bazan E.
Cellular Characterization of Epidermal Growth Factor-expanded Free-floating Neurospheres.
J Histochem Cytochem.    impact factor:   2.675
2003;  51(1): 89-103

162:  Farnum CE, Lee AO, O'Hara K, Wilsman NJ.
Effect of Short-Term Fasting on Bone Elongation Rates: An Analysis of Catch-up Growth in Young Male Rats.
Pediatr Res.    impact factor:   2.671
2003;  53(1): 33-41

163:  Inturrisi CE.
Clinical pharmacology of opioids for pain.
Clin J Pain.    impact factor:   2.662
2002;  18(4 Suppl): S3-13

164:  Bergstein I.
A non-Darwinian role for mutagenesis in stem cell-derived cancers.
Mol Carcinog.    impact factor:   2.589
2003;  36(1): 1-5

165:  Sundstrom M, Vliagoftis H, Karlberg P, Butterfield JH, Nilsson K, Metcalfe DD, Nilsson G.
Functional and phenotypic studies of two variants of a human mast cell line with a distinct set of mutations in the c-kit proto-oncogene.
Immunology.    impact factor:   2.575
2003;  108(1): 89-97

166:  Blom B, Ligthart SJ, Schotte R, Spits H.
Developmental origin of pre-DC2.
Hum Immunol.    impact factor:   2.558
2002;  63(12): 1072-80

167:  Sonneveld P, Segeren CM.
Changing concepts in multiple myeloma: from conventional chemotherapy to high-dose treatment.
Eur J Cancer.    impact factor:   2.537
2003;  39(1): 9-18

168:  Takada T, Suzuki Y, Kondo Y, Kadota N, Kobayashi K, Nito S, Kimura H, Torii R.
Monkey embryonic stem cell lines expressing green fluorescent protein.
Cell Transplant.    impact factor:   2.493
2002;  11(7): 631-5

169:  Raveh E, Cohen S, Raz T, Yakir D, Grava A, Goldschmidt EE.
Increased growth of young citrus trees under reduced radiation load in a semi-arid climate(1).
J Exp Bot.    impact factor:   2.482
2003;  54(381): 365-373

170:  McElrone AJ, Sherald JL, Forseth IN.
Interactive effects of water stress and xylem-limited bacterial infection on the water relations of a host vine.
J Exp Bot.    impact factor:   2.482
2003;  54(381): 419-30

171:  Iwasaki Y, Ohsugi S, Takemura Y, Nagata K, Harada H, Nakagawa M.
Multidisciplinary therapy including high-dose chemotherapy followed by peripheral blood stem cell transplantation for invasive thymoma.
Chest.    impact factor:   2.41
2002;  122(6): 2249-52

172:  Stenmark KR, Gerasimovskaya E, Nemenoff RA, Das M.
Hypoxic activation of adventitial fibroblasts: role in vascular remodeling.
Chest.    impact factor:   2.41
2002;  122(6 Suppl): 326S-34S

173:  Hassan M, Nilsson C, Hassan Z, Gungor T, Aschan J, Winiarski J, Hentschke P, Ringden O, Eber S, Seger R, Ljungman P.
A phase II trial of liposomal busulphan as an intravenous myeloablative agent prior to stem cell transplantation: 500 mg/m(2) as a optimal total dose for conditioning.
Bone Marrow Transplant.    impact factor:   2.396
2002;  30(12): 833-41

174:  Chin-Yee IH, Keeney M, Stewart AK, Belch A, Bence-Buckler I, Couban S, Howson-Jan K, Rubinger M, Stewart D, Sutherland R, Paragamian V, Bhatia M, Foley R.
Optimising parameters for peripheral blood leukapheresis after r-metHuG-CSF (filgrastim) and r-metHuSCF (ancestim) in patients with multiple myeloma: a temporal analysis of CD34(+) absolute counts and subsets.
Bone Marrow Transplant.    impact factor:   2.396
2002;  30(12): 851-860

175:  Bubnic SJ, Wang XH, Clark BR, Keating A.
W/W(v) marrow stromal cells engraft and enhance early erythropoietic progenitors in unconditioned Sl/Sl(d) murine recipients.
Bone Marrow Transplant.    impact factor:   2.396
2002;  30(12): 867-72

176:  Viret F, Bertucci F, Genre D, Gravis G, Chabannon C, Conte M, Houvenaeghel G, Maraninchi D, Viens P.
Intensive sequential dose dense chemotherapy with stem cell support as first-line treatment in advanced ovarian carcinoma: a phase II study.
Bone Marrow Transplant.    impact factor:   2.396
2002;  30(12): 879-84

177:  Chen CI, Roitman D, Tsang R, Stewart AK, Keating A, Crump M.
'Relative' chemotherapy sensitivity: the impact of number of salvage regimens prior to autologous stem cell transplant for relapsed and refractory aggressive non-Hodgkin's lymphoma.
Bone Marrow Transplant.    impact factor:   2.396
2002;  30(12): 885-91

178:  Kremens B, Gruhn B, Klingebiel T, Hasan C, Laws HJ, Koscielniak E, Hero B, Selle B, Niemeyer C, Finckenstein FG, Schulz A, Wawer A, Zintl F, Graf N.
High-dose chemotherapy with autologous stem cell rescue in children with nephroblastoma.
Bone Marrow Transplant.    impact factor:   2.396
2002;  30(12): 893-8

179:  Wernstedt P, Brune M, Andersson PO, Gustavsson B, Stockelberg D, Wadenvik H.
Favorable outcome with STI571 (imatinib mesylate) and allogeneic stem cell transplantation in a case of Ph+ chemorefractory acute lymphocytic leukaemia.
Bone Marrow Transplant.    impact factor:   2.396
2002;  30(12): 971-3

180:  Massenkeil G, Rackwitz S, Genvresse I, Rosen O, Dorken B, Arnold R.
Basiliximab is well tolerated and effective in the treatment of steroid-refractory acute graft-versus-host disease after allogeneic stem cell transplantation.
Bone Marrow Transplant.    impact factor:   2.396
2002;  30(12): 899-903

181:  Osorio S, De La Camara R, Golbano N, Marti E, Fedele CG, Nieto S, Manzanares R, Fernandez-Ranada JM.
Progressive multifocal leukoencephalopathy after stem cell transplantation, unsuccessfully treated with cidofovir.
Bone Marrow Transplant.    impact factor:   2.396
2002;  30(12): 963-6

182:  Mattei D, Mordini N, Lo Nigro C, Ghirardo D, Ferrua MT, Osenda M, Gallamini A, Bacigalupo A, Viscoli C.
Voriconazole in the management of invasive aspergillosis in two patients with acute myeloid leukemia undergoing stem cell transplantation.
Bone Marrow Transplant.    impact factor:   2.396
2002;  30(12): 967-70

183:  Jantunen E, Anttila VJ, Ruutu T.
Aspergillus infections in allogeneic stem cell transplant recipients: have we made any progress?
Bone Marrow Transplant.    impact factor:   2.396
2002;  30(12): 925-9

184:  Burns LJ, Miller W, Kandaswamy C, DeFor TE, MacMillan ML, Van Burik JA, Weisdorf DJ.
Randomized clinical trial of ganciclovir vs acyclovir for prevention of cytomegalovirus antigenemia after allogeneic transplantation.
Bone Marrow Transplant.    impact factor:   2.396
2002;  30(12): 945-51

185:  Hale G, Slavin S, Goldman JM, Mackinnon S, Giralt S, Waldmann H.
Alemtuzumab (Campath-1H) for treatment of lymphoid malignancies in the age of nonmyeloablative conditioning?
Bone Marrow Transplant.    impact factor:   2.396
2002;  30(12): 797-804

186:  Gratwohl A, Baldomero H, Passweg J, Urbano-Ispizua A.
Increasing use of reduced intensity conditioning transplants: report of the 2001 EBMT activity survey.
Bone Marrow Transplant.    impact factor:   2.396
2002;  30(12): 813-31

187:  Ohkawara B, Okuno M, Ishii T, Horiuchi M, Tomooka Y.
Characterization of a multipotent neural progenitor cell line cloned from an adult p53(-/-) mouse cerebellum.
Brain Res.    impact factor:   2.302
2003;  959(1): 11-9

188:  Kato S, Wang Y, Papuashvili N, Okada YC.
Stable synchronized high-frequency signals from the main sensory and spinal nuclei of the pig activated by Abeta fibers of the maxillary nerve innervating the snout.
Brain Res.    impact factor:   2.302
2003;  959(1): 1-10

189:  Perriquet O, Touzet H, Dauchet M.
Finding the common structure shared by two homologous RNAs.
Bioinformatics.    impact factor:   2.259
2003;  19(1): 108-16

190:  Ozkul Y, Bozlar S.
Effects of fluoxetine on habituation of pattern reversal visually evoked potentials in migraine prophylaxis.
Headache.    impact factor:   2.25
2002;  42(7): 582-7

191:  Boucher Y, Simons CT, Cuellar JM, Jung SW, Carstens MI, Carstens E.
Activation of brain stem neurons by irritant chemical stimulation of the throat assessed by c-fos immunohistochemistry.
Exp Brain Res.    impact factor:   2.246
2003;  148(2): 211-8

192:  Erni R, Heinrich H, Kostorz G.
Quantitative characterisation of chemical inhomogeneities in Al-Ag using high-resolution Z-contrast STEM.
Ultramicroscopy.    impact factor:   2.244
2003;  94(2): 125-33

193:  Tsuchida H, Hashimoto J, Crawford E, Manske P, Lou J.
Engineered allogeneic mesenchymal stem cells repair femoral segmental defect in rats.
J Orthop Res.    impact factor:   2.233
2003;  21(1): 44-53

194:  Popova NV, Tryson KA, Wu KQ, Morris RJ.
Evidence that the keratinocyte colony number is genetically controlled.
Exp Dermatol.    impact factor:   2.183
2002;  11(6): 503-8

195:  Spinella MJ, Kerley JS, White KA, Curtin JC.
Retinoid Target Gene Activation during Induced Tumor Cell Differentiation: Human Embryonal Carcinoma as a Model.
J Nutr.    impact factor:   2.15
2003;  133(1): 273S-6S

196:  Choi JH, Ha J, Park JH, Lee JY, Lee YS, Park HJ, Choi JW, Masuda Y, Nakaya K, Lee KT.
Costunolide triggers apoptosis in human leukemia U937 cells by depleting intracellular thiols.
Jpn J Cancer Res.    impact factor:   2.12
2002;  93(12): 1327-33

197:  Mastino A, Favalli C, Camilli AR, Malerba C, Grelli S, Calugi A.
Umbilical Cord Blood: the Role of Apoptosis in the Control of CD34+ Cell Counts.
Placenta.    impact factor:   2.101
2003;  24(1): 113-5

198:  Carroll JL.
Plasticity in Respiratory Motor Control: Invited Review: Developmental plasticity in respiratory control.
J Appl Physiol.    impact factor:   2.081
2003;  94(1): 375-89

199:  Dallorso S, Rondelli R, Messina C, Pession A, Giorgiani G, Fagioli F, Locatelli F, Manzitti C, Balduzzi A, Prete A, Cesaro S, Lanino E, Dini G.
Clinical benefits of granulocyte colony-stimulating factor therapy after hematopoietic stem cell transplant in children: results of a prospective randomized trial.
Haematologica.    impact factor:   2.074
2002;  87(12): 1274-80

200:  Consoli U, Milone G, Guido G, Consoli C, Palumbo GA, Giustolisi R.
STI571 (GLIVEC) induced hematologic, cytogenetic and molecular remission in a cml patient relapsing with accelerated phase after allogeneic stem cell transplantation.
Haematologica.    impact factor:   2.074
2002;  87(12): ECR37

201:  Alessandrino EP, Amadori S, Barosi G, Cazzola M, Grossi A, Liberato LN, Locatelli F, Marchetti M, Morra E, Rebulla P, Visani G, Tura S.
Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology.
Haematologica.    impact factor:   2.074
2002;  87(12): 1286-306

202:  Six I, Gasan G, Mura E, Bordet R.
Beneficial effect of pharmacological mobilization of bone marrow in experimental cerebral ischemia.
Eur J Pharmacol.    impact factor:   2.047
2003;  458(3): 327-328

203:  Atwell BJ, Henery ML, Whitehead D.
Sapwood development in Pinus radiata trees grown for three years at ambient and elevated carbon dioxide partial pressures.
Tree Physiol.    impact factor:   2.042
2003;  23(1): 13-21

204:  [No authors listed]
Post-transplant complications. cataracts in patients receiving stem cell transplantation after conditioning with total body irradiation. Aristei C,* Alessandro M, Santucci A, Aversa F, Tabillo A, Carotti A, Latini RA, Cagini C, Latini P. Bone Marrow Transplant 2002;29:503-507.
Am J Ophthalmol.    impact factor:   2.012
2003;  135(1): 126

205:  Devine SM, Adkins DR, Khoury H, Brown RA, Vij R, Blum W, DiPersio JF.
Recent advances in allogeneic hematopoietic stem-cell transplantation.
J Lab Clin Med.    impact factor:   1.989
2003;  141(1): 7-32

206:  Schlotzhauer AV, Liang BA.
Definitions and implications of death.
Hematol Oncol Clin North Am.    impact factor:   1.979
2002;  16(6): 1397-413

207:  Gozdz A, Szczepanska-Sadowska E, Maslinski W, Kumosa M, Szczepanska K, Dobruch J.
Differential expression of vasopressin V1a and V1b receptors mRNA in the brain of renin transgenic TGR(mRen2)27 and Sprague-Dawley rats.
Brain Res Bull.    impact factor:   1.977
2003;  59(5): 399-403

208:  Hofmann MC, Van Der Wee KS, Dargart JL, Dirami G, Dettin L, Dym M.
Establishment and characterization of neonatal mouse sertoli cell lines.
J Androl.    impact factor:   1.972
2003;  24(1): 120-30

209:  Han YM, Kang YK, Koo DB, Lee KK.
Nuclear reprogramming of cloned embryos produced in vitro.
Theriogenology.    impact factor:   1.923
2003;  59(1): 33-44

210:  Amzica F.
Physiology of Sleep and Wakefulness as it Relates to the Physiology of Epilepsy.
J Clin Neurophysiol.    impact factor:   1.915
2002;  19(6): 488-503

211:  Pajor L, Kereskai L, Zsdral K, Nagy Z, Vass JA, Jakso P, Radvanyi G.
Philadelphia chromosome and/or bcr-abl mRNA-positive primary thrombocytosis: morphometric evidence for the transition from essential thrombocythaemia to chronic myeloid leukaemia type of myeloproliferation.
Histopathology.    impact factor:   1.9
2003;  42(1): 53-60

212:  Engel AG, Ohno K, Sine SM.
Congenital myasthenic syndromes: Progress over the past decade.
Muscle Nerve.    impact factor:   1.898
2003;  27(1): 4-25

213:  Schilder RJ, Brady MF, Spriggs D, Shea T.
Pilot evaluation of high-dose carboplatin and paclitaxel followed by high-dose melphalan supported by peripheral blood stem cells in previously untreated advanced ovarian cancer: a gynecologic oncology group study.
Gynecol Oncol.    impact factor:   1.86
2003;  88(1): 3-8

214:  Jones K, Georgiou M, Hyatt D, Spencer T, Thomas H.
Endometrial adenocarcinoma following the insertion of a Mirena IUCD.
Gynecol Oncol.    impact factor:   1.86
2002;  87(2): 216-8

215:  Seitz V, Hummel M, Walter J, Stein H.
Evolution of classic Hodgkin lymphoma in correlation to changes in the lymphoid organ structure of vertebrates.
Dev Comp Immunol.    impact factor:   1.857
2003;  27(1): 43-53

216:  Stern JM.
Nutritional assesment and management of malabsorption in the hematopoietic stem cell transplant patient.
J Am Diet Assoc.    impact factor:   1.857
2002;  102(12): 1812-5; discussion 1815-6

217:  Liour SS, Yu RK.
Differential effects of three inhibitors of glycosphingolipid biosynthesis on neuronal differentiation of embryonal carcinoma stem cells.
Neurochem Res.    impact factor:   1.755
2002;  27(11): 1507-12

218:  Bongarzone ER.
Induction of oligodendrocyte fate during the formation of the vertebrate neural tube.
Neurochem Res.    impact factor:   1.755
2002;  27(11): 1361-9

219:  Francescangeli E, Grassi S, Pettorossi VE, Goracci G.
Activation of PAF-synthesizing enzymes in rat brain stem slices after LTP induction in the medial vestibular nuclei.
Neurochem Res.    impact factor:   1.755
2002;  27(11): 1465-71

220:  Wen T, Gu P, Minning TA, Wu Q, Liu M, Chen F, Liu H, Huang H.
Microarray analysis of neural stem cell differentiation in the striatum of the fetal rat.
Cell Mol Neurobiol.    impact factor:   1.752
2002;  22(4): 407-16

221:  Sherman MD.
Rehab Rounds: The Support and Family Education (SAFE) Program: Mental Health Facts for Families.
Psychiatr Serv.    impact factor:   1.747
2003;  54(1): 35-7

222:  Hiromatsu Y, Toda S.
Mast cells and angiogenesis.
Microsc Res Tech.    impact factor:   1.746
2003;  60(1): 64-9

223:  Smith DL, Evans CA, Pierce A, Gaskell SJ, Whetton AD.
Changes in the proteome associated with the action of bcr-abl tyrosine kinase are not related to transcriptional regulation.
Mol Cell Proteomics.    impact factor:   1.744
2002;  1(11): 876-84

224:  Tai MH, Olson LK, Madhukar BV, Linning KD, Van Camp L, Tsao MS, Trosko JE.
Characterization of gap junctional intercellular communication in immortalized human pancreatic ductal epithelial cells with stem cell characteristics.
Pancreas.    impact factor:   1.685
2003;  26(1): e18-26

225:  Feraud O, Vittet D.
Murine embryonic stem cell in vitro differentiation: applications to the study of vascular development.
Histol Histopathol.    impact factor:   1.601
2003;  18(1): 191-9

226:  Barton FE 2nd, Akin DE, Morrison WH, Ulrich A, Archibald DD.
Analysis of fiber content in flax stems by near-infrared spectroscopy.
J Agric Food Chem.    impact factor:   1.56
2002;  50(26): 7576-80

227:  Liu WC, Hsu MH, Kuo AY.
Modelling of hydrodynamics and cohesive sediment transport in Tanshui River estuarine system, Taiwan.
Mar Pollut Bull.    impact factor:   1.539
2002;  44(10): 1076-88

228:  Dunkley C, Farnsworth A, Mason S, Dodd M, Gibbin K.
Screening and follow up assessment in three cases of auditory neuropathy.
Arch Dis Child.    impact factor:   1.519
2003;  88(1): 25-6

229:  Shankar AG, Ashley S, Craft AW, Pinkerton CR.
Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma.
Med Pediatr Oncol.    impact factor:   1.518
2003;  40(3): 141-7

230:  Katzenstein HM, Kletzel M, Reynolds M, Superina R, Gonzalez-Crussi F.
Metastatic malignant rhabdoid tumor of the liver treated with tandem high-dose therapy and autologous peripheral blood stem cell rescue.
Med Pediatr Oncol.    impact factor:   1.518
2003;  40(3): 199-201

231:  Carral A, de la Rubia J, Marti;n G, Molla S, Marti;nez J, Sanz GF, Soler MA, Jarque I, Jimenez C, Sanz MA.
Factors influencing the collection of peripheral blood stem cells in patients with acute myeloblastic leukemia and non-myeloid malignancies.
Leuk Res.    impact factor:   1.502
2003;  27(1): 5-12

232:  Sanchez S, Alarcon de la Lastra C, Ortiz P, Motilva V, Martin MJ.
Gastrointestinal tolerability of metamizol, acetaminophen, and diclofenac in subchronic treatment in rats.
Dig Dis Sci.    impact factor:   1.498
2002;  47(12): 2791-8

233:  Krieger LM.
Skin potions, stem cells, and growth hormones: the economic costs of selling patients dubious products and services.
Plast Reconstr Surg.    impact factor:   1.482
2003;  111(1): 485-6

234:  Dvorankova B, Motlik J, Holikova Z, Vacik J, Smetana K Jr.
Dolichos biflorus agglutinin-binding site expression in basal keratinocytes is associated with cell differentiation.
Biol Cell.    impact factor:   1.477
2002;  94(6): 365-73

235:  Murch SJ, Rupasinghe HP, Saxena PK.
An in vitro and Hydroponic Growing System for Hypericin, Pseudohypericin, and Hyperforin Production of St. John's Wort (Hypericum perforatum CV New Stem).
Planta Med.    impact factor:   1.438
2002;  68(12): 1108-12

236:  Zhang HJ, Tamez PA, Aydogmus Z, Tan GT, Saikawa Y, Hashimoto K, Nakata M, Hung NV, Xuan le T, Cuong NM, Soejarto DD, Pezzuto JM, Fong HH.
Antimalarial Agents from Plants. III. Trichothecenes from Ficus fistulosa and Rhaphidophora decursiva.
Planta Med.    impact factor:   1.438
2002;  68(12): 1088-91

237:  Pauluhn J, Leng G.
Concentration-dependence of biomarkers of exposure of methylenediphenyl-diisocyanate following acute inhalation exposure of rats.
Toxicology.    impact factor:   1.343
2003;  185(1-2): 35-48

238:  Dwivedi SK, Dey S.
Medicinal herbs: a potential source of toxic metal exposure for man and animals in India.
Arch Environ Health.    impact factor:   1.308
2002;  57(3): 229-31

239:  Baumann M, Korenke GC, Weddige-Diedrichs A, Wilichowski E, Hunneman DH, Wilken B, Brockmann K, Klingebiel T, Niethammer D, Kuhl J, Ebell W, Hanefeld F.
Haematopoietic stem cell transplantation in 12 patients with cerebral X-linked adrenoleukodystrophy.
Eur J Pediatr.    impact factor:   1.28
2003;  162(1): 6-14

240:  Dassler CL, Schulz KS, Kass P, Stover SM.
The effects of femoral stem and neck length on cement strains in a canine total hip replacement model.
Vet Surg.    impact factor:   1.273
2003;  32(1): 37-45

241:  Sakoff JA, De Waal E, Garg MB, Denham J, Scorgie FE, Enno A, Lincz LF, Ackland SP.
Telomere length in haemopoietic stem cells can be determined from that of mononuclear blood cells or whole blood.
Leuk Lymphoma.    impact factor:   1.252
2002;  43(10): 2017-20

242:  Arai H, Arai Y, Haraguchi K, Nakamura Y, Tsurumi S, Maki K, Aoyagi A, Nakamura Y, Saito K, Mitani K.
Successful HLA-identical unrelated allogeneic bone marrow transplantation with a very low dose of stem cells for a patient with chronic myeloid leukemia in blast crisis.
Leuk Lymphoma.    impact factor:   1.252
2002;  43(10): 2067-9

243:  Jantunen E, Kuittinen T, Nousiainen T.
A pilot study on feasibility and efficacy of amifostine preceding high-dose melphalan with autologous stem cell support in myeloma patients.
Leuk Lymphoma.    impact factor:   1.252
2002;  43(10): 1961-5

244:  Deliliers GL, Annaloro C, Marconi M, Soligo D, Morandi P, Luchesini C, Tagliaferri E, Della Volpe A.
Harvesting of autologous blood stem cells after a mobilising regimen with low-dose cyclophosphamide.
Leuk Lymphoma.    impact factor:   1.252
2002;  43(10): 1957-60

245:  Allford SL, Bird JM, Marks DI.
Thrombotic thrombocytopenic purpura following stem cell transplantation.
Leuk Lymphoma.    impact factor:   1.252
2002;  43(10): 1921-6

246:  Griffith M, Hakim M, Shimmura S, Watsky MA, Li F, Carlsson D, Doillon CJ, Nakamura M, Suuronen E, Shinozaki N, Nakata K, Sheardown H.
Artificial human corneas: scaffolds for transplantation and host regeneration.
Cornea.    impact factor:   1.198
2002;  21(7 Suppl): S54-61

247:  Chang G, McGarigle C, Koby D, Antin JH.
Symptoms of pain and depression in related marrow donors: changes after transplant.
Psychosomatics.    impact factor:   1.174
2003;  44(1): 59-64

248:  Plzak J, Haninec P, Smetana K Jr, Holikova Z, Andre S, Kuwabara I, Liu FT, Gabius HJ.
Craniopharyngioma: a case report and comparative galectin histochemical analysis.
Histochem J.    impact factor:   1.161
2002;  34(3-4): 117-22

249:  Hescheler J, Fleischmann BK.
Regulation of voltage-dependent Ca2+ channels in the early developing heart: role of beta1 integrins.
Basic Res Cardiol.    impact factor:   1.148
2002;  97 Suppl 1: I153-8

250:  Robinson B, Duwig C, Bolan N, Kannathasan M, Saravanan A.
Uptake of arsenic by New Zealand watercress (Lepidium sativum).
Sci Total Environ.    impact factor:   1.126
2003;  301(1-3): 67-73

251:  Morikawa T, Tao J, Ueda K, Matsuda H, Yoshikawa M.
Medicinal Foodstuffs. XXXI. Structures of New Aromatic Constituents and Inhibitors of Degranulation in RBL-2H3 Cells from a Japanese Folk Medicine, the Stem Bark of Acer nikoense.
Chem Pharm Bull (Tokyo).    impact factor:   1.117
2003;  51(1): 62-7

252:  Katoh T, Tanaka R, Takeo M, Nishide K, Node M.
A New Synthesis of a Potent Cancer Chemopreventive Agent, 13-Oxo-15,16-dinorlabda-8(17),11E-dien-19-oic Acid from trans-Communic Acid.
Chem Pharm Bull (Tokyo).    impact factor:   1.117
2002;  50(12): 1625-9

253:  Lowes KN, Croager EJ, Olynyk JK, Abraham LJ, Yeoh GC.
Oval cell-mediated liver regeneration: Role of cytokines and growth factors.
J Gastroenterol Hepatol.    impact factor:   1.116
2003;  18(1): 4-12

254:  Marita JM, Ralph J, Hatfield RD, Guo D, Chen F, Dixon RA.
Structural and compositional modifications in lignin of transgenic alfalfa down-regulated in caffeic acid 3-O-methyltransferase and caffeoyl coenzyme A 3-O-methyltransferase.
Phytochemistry.    impact factor:   1.106
2003;  62(1): 53-65

255:  King RW, Evans LT, Mander LN, Moritz T, Pharis RP, Twitchin B.
Synthesis of gibberellin GA(6) and its role in flowering of Lolium temulentum.
Phytochemistry.    impact factor:   1.106
2003;  62(1): 77-82

256:  Sato T, Kogawa K, Iyama S, Kobayashi D, Sato Y, Kuribayashi K, Takada K, Hagiwara S, Oku T, Takahashi S, Matsunaga T, Takahashi M, Terui T, Kato J, Niitsu Y.
Successful treatment of advanced peripheral T-cell lymphoma with an angiocentric growth pattern complicated with hemophagocytic syndrome by high-dose chemotherapy and autologous peripheral blood stem cell transplantation.
Ann Hematol.    impact factor:   1.101
2002;  81(12): 739-43

257:  Carrasco M, Sureda A, Martinez C, Carmona M, Altes A, Martin-Henao GA, Aventin A, Sierra J.
Prognostic factors influencing feasibility of cytogenetic and molecular analysis in leukapheresis products in chronic myelogenous leukemia patients.
Ann Hematol.    impact factor:   1.101
2002;  81(12): 710-6

258:  Faulhaber M, Wormann B, Ganser A, Verbeek W.
In vitro response of myelodysplastic megakaryocytopoiesis to megakaryocyte growth and development factor (MGDF).
Ann Hematol.    impact factor:   1.101
2002;  81(12): 695-700

259:  Amano T, Inamura T, Wu CM, Kura S, Nakamizo A, Inoha S, Miyazono M, Ikezaki K.
Effects of single low dose irradiation on subventricular zone cells in juvenile rat brain.
Neurol Res.    impact factor:   1.1
2002;  24(8): 809-16

260:  Saiz A, Graus F.
[Transplantation of haematopoietic stem cells in multiple sclerosis]
Rev Neurol.    impact factor:   1.013
2002;  35(12): 1136-41

261:  Pahl JW, Mendelssohn IA, Henry CB Jr, Hess TJ.
Recovery Trajectories After In Situ Burning of an Oiled Wetland in Coastal Louisiana, USA.
Environ Manage.    impact factor:   .976
2003;  31(2): 236-251

262:  Pachernik J, Esner M, Bryja V, Dvorak P, Hampl A.
Neural differentiation of mouse embryonic stem cells grown in monolayer.
Reprod Nutr Dev.    impact factor:   .922
2002;  42(4): 317-26

263:  Ueda S, Ikeda H, Mizuki M, Ishiko J, Matsumura I, Tanaka H, Shibayama H, Sugahara H, Takai E, Zhang X, Machii T, Kanakura Y.
Constitutive activation of c-kit by the juxtamembrane but not the catalytic domain mutations is inhibited selectively by tyrosine kinase inhibitors STI571 and AG1296.
Int J Hematol.    impact factor:   .918
2002;  76(5): 427-35

264:  Engh CA Jr, Ellis TJ, Koralewicz LM, McAuley JP, Engh CA Sr.
Extensively porous-coated femoral revision for severe femoral bone loss: Minimum 10-year follow-up.
J Arthroplasty.    impact factor:   .918
2002;  17(8): 955-60

265:  Kishida Y, Sugano N, Ohzono K, Sakai T, Nishii T, Yoshikawa H.
Stem fracture of the cementless spongy metal lubeck hip prosthesis.
J Arthroplasty.    impact factor:   .918
2002;  17(8): 1021-7

266:  Usui N, Dobashi N, Asai O, Yano S, Yahagi Y, Saito T, Yamaguchi Y, Kasama K, Okawa Y, Sekiguchi N, Takei Y, Sugiyama K, Ogasawara Y, Ohtsubo H, Kaito K, Kobayashi M.
Intensified daunorubicin in induction therapy and autologous peripheral blood stem cell transplantation in postremission therapy (Double-7 protocol) for adult acute myeloid leukemia.
Int J Hematol.    impact factor:   .918
2002;  76(5): 436-45

267:  Oh HS, Choi JH, Park CK, Jung CW, Lee SI, Park Q, Suh C, Kim SB, Chi HS, Lee JH, Cho EK, Bang SM, Ahn MJ.
Comparison of microvessel density before and after peripheral blood stem cell transplantation in multiple myeloma patients and its clinical implications: multicenter trial.
Int J Hematol.    impact factor:   .918
2002;  76(5): 465-70

268:  Gill HS, Alfaro-Adrian J, Alfaro-Adrian C, McLardy-Smith P, Murray DW.
The effect of anteversion on femoral component stability assessed by radiostereometric analysis.
J Arthroplasty.    impact factor:   .918
2002;  17(8): 997-1005

269:  Kawano S, Morotomi T, Toyono T, Nakamura N, Uchida T, Ohishi M, Toyoshima K, Harada H.
Establishment of dental epithelial cell line (HAT-7) and the cell differentiation dependent on Notch signaling pathway.
Connect Tissue Res.    impact factor:   .901
2002;  43(2-3): 409-12

270:  Harada H, Toyono T, Toyoshima K, Ohuchi H.
FGF10 maintains stem cell population during mouse incisor development.
Connect Tissue Res.    impact factor:   .901
2002;  43(2-3): 201-4

271:  Bonnet BR, Wisniewsk C, Reissmann CB, Nogueira AC, Andreoli CV, Barbieri SJ.
Effects of substrates composed of biosolids on the production of Eucalyptus viminalis, Schinus terebinthifolius and Mimosa scabrella seedlings and on the nutritional status of Schinus terebinthifolius seedlings.
Water Sci Technol.    impact factor:   .895
2002;  46(10): 239-46

272:  Ruiz-Genao DP, Sanz-Sanchez T, Bartolome-Gonzalez B, Fernandez-Herrera J, Garcia-Diez A.
Dermatomyositis-like reaction induced by chemotherapeutical agents.
Int J Dermatol.    impact factor:   .867
2002;  41(12): 885-7

273:  Saleem R, Ahmad SI, Ahmed M, Faizi Z, Zikr-Ur-Rehman S, Ali M, Faizi S.
Hypotensive Activity and Toxicology of Constituents from Bombax ceiba Stem Bark.
Biol Pharm Bull.    impact factor:   .844
2003;  26(1): 41-6

274:  Karabakhtsian R, Heller DS, Singhal P, Sama J.
Malignant mixed mesodermal tumor in a young woman with polycystic ovary syndrome. A case report.
J Reprod Med.    impact factor:   .824
2002;  47(11): 946-8

275:  Robinson SN, Talmadge JE.
Sustained release of growth factors.
In Vivo.    impact factor:   .794
2002;  16(6): 535-40

276:  Warner HR.
Recent progress in understanding the relationships among aging, replicative senescence, cell turnover and cancer.
In Vivo.    impact factor:   .794
2002;  16(6): 393-6

277:  Krueger GR, Marshall GR, Junker U, Schroeder H, Buja LM, Wang G.
Growth factors, cytokines, chemokines and neuropeptides in the modeling of T-cells.
In Vivo.    impact factor:   .794
2002;  16(5): 365-86

278:  Hasegawa N, Watanabe M, Inoue H, Kobayashi T, Kojima H, Manome Y.
Mutant ICR mouse, kuru2, manifests hearing impairment and abnormal behavior.
In Vivo.    impact factor:   .794
2002;  16(5): 349-60

279:  Sanchez-Gonzalez B, Fernandez-Abellan P, Rivas C, Villarrubia B.
[Cytomegalovirus enteritis after autologous peripheral blood stem cell transplantation]
Med Clin (Barc).    impact factor:   .75
2002;  119(19): 757

280:  Gil De Pertierra AA.
Nomimoscolex semenasae n. sp. (Proteocephalidea: Monticelliidae), a cestode parasite of Diplomystes viedmensis (Pisces: Siluriformes) from the Patagonian region of Argentina.
Syst Parasitol.    impact factor:   .74
2002;  53(3): 183-90

281:  Dongmo AB, Kamanyi A, Dzikouk G, Chungag-Anye Nkeh B, Tan PV, Nguelefack T, Nole T, Bopelet M, Wagner H.
Anti-inflammatory and analgesic properties of the stem bark extract of Mitragyna ciliata (Rubiaceae) Aubrev. & Pellegr.
J Ethnopharmacol.    impact factor:   .687
2003;  84(1): 17-21

282:  Slavin S.
Non-myeloablative stem cell transplantation for induction of host-versus-graft tolerance for adoptive immunotherapy of malignant and nonmalignant diseases and towards transplantation of organ allografts.
Transplant Proc.    impact factor:   .678
2002;  34(8): 3371-3

283:  Holowiecki J, Giebel S, Wojnar J, Krawczyk-Kulis M, Stella-Holowiecka B, Kachel L, Wojciechowska M, Markiewicz M, Kata D.
Autologous hematopoietic stem cell transplantation for high-risk Hodgkin's disease: a single-center experience with the first 100 patients.
Transplant Proc.    impact factor:   .678
2002;  34(8): 3378-83

284:  Conti P, Kempuraj D, Di Gioacchino M, Boucher W, Letourneau R, Kandere K, Barbacane RC, Reale M, Felaco M, Frydas S, Theoharides TC.
Interleukin-6 and mast cells.
Allergy Asthma Proc.    impact factor:   .67
2002;  23(5): 331-5

285:  Faden R.
Spare parts for the rich? Everybody seems to have a view on embryo research. But stem cell treatments raise moral dilemmas that few have even started to consider.
New Sci.    impact factor:   .635
2002;  176(2365): 27

286:  Aul C, Schroeder M, Giagounidis A.
[Medicinal therapy of malignant lymphomas]
Radiologe.    impact factor:   .621
2002;  42(12): 943-53

287:  Fukumori F, Kishii M.
Molecular cloning and transcriptional analysis of the alkyl hydroperoxide reductase genes from Pseudomonas putida KT2442.
J Gen Appl Microbiol.    impact factor:   .613
2001;  47(5): 269-277

288:  Janig W, Habler HJ.
[Physiology and pathophysiology of visceral pain]
Schmerz.    impact factor:   .593
2002;  16(6): 429-46

289:  Schill S, Thabe H, Grifka J.
[Differential therapy for the rheumatoid shoulder]
Orthopade.    impact factor:   .583
2002;  31(12): 1132-44

290:  Lombardi AV Jr, Mallory TH, Fada RA, Adams JB.
Stem modularity: rarely necessary in primary total hip arthroplasty.
Orthopedics.    impact factor:   .49
2002;  25(12): 1385-7

291:  Haluzik M, Markova M, Slaby JJ, Jiskra J, Krizova J, Hass T.
The changes of serum leptin and soluble leptin receptor levels in patients undergoing mobilization of peripheral blood stem cells before autologous stem cells transplantation.
Endocr Res.    impact factor:   .475
2002;  28(3): 189-97

292:  Yokoyama O, Komatsu K, Ishiura Y, Akino H, Kodama K, Yotsuyanagi S, Moriyama N, Nagasaka Y, Ito Y, Namiki M.
Overactive bladder--experimental aspects.
Scand J Urol Nephrol Suppl.    impact factor:   .448
2002;  (210): 59-64

293:  Cakirer S.
Chiari III malformation. Varieties of MRI appearances in two patients.
Clin Imaging.    impact factor:   .368
2003;  27(1): 1-4

294:  Prelle K, Zink N, Wolf E.
Pluripotent stem cells--model of embryonic development, tool for gene targeting, and basis of cell therapy.
Anat Histol Embryol.    impact factor:   .241
2002;  31(3): 169-86

295:  Ansari SA, Nachanakian A, Biary NM.
Current surgical treatment of Parkinsons disease.
Saudi Med J.    impact factor:   .172
2002;  23(11): 1319-23

296:  Geissler K, Agis H, Sagaster V.
[In Process Citation]
Acta Med Austriaca.    impact factor:   .158
2002;  29 Suppl 59: 66-8

297:  Boeckxstaens GE.
Understanding and controlling the enteric nervous system.
Best Pract Res Clin Gastroenterol.    impact factor:   .067
2002;  16(6): 1013-23

298:  Freedman MH, Alter BP.
Malignant myeloid transformation in congenital forms of neutropenia.
Isr Med Assoc J.    impact factor:   .027
2002;  4(11): 1011-4

299:  Zhao J, Hao HN, Lyman WD.
Cryopreserved fetal human liver hematopoietic progenitor cells for repopulating immune-deficient mouse bone marrow.
Isr Med Assoc J.    impact factor:   .027
2002;  4(11): 989-91

300:  Biolo G, Antonione R, Barazzoni R, Zanetti M, Guarnieri G.
Mechanisms of altered protein turnover in chronic diseases: a review of human kinetic studies.
Curr Opin Clin Nutr Metab Care.    impact factor:   0
2003;  6(1): 55-63

301:  O'Dwyer ME.
Chronic myelogenous leukemia.
Curr Opin Oncol.    impact factor:   0
2003;  15(1): 10-5

302:  Horvath H, Rostoks N, Brueggeman R, Steffenson B, Von Wettstein D, Kleinhofs A.
Genetically engineered stem rust resistance in barley using the Rpg1 gene.
Proc Natl Acad Sci U S A.    impact factor:   0
2003;  100(1): 364-9

303:  Moore FL, Jaruzelska J, Fox MS, Urano J, Firpo MT, Turek PJ, Dorfman DM, Reijo Pera RA.
Human Pumilio-2 is expressed in embryonic stem cells and germ cells and interacts with DAZ (Deleted in AZoospermia) and DAZ-Like proteins.
Proc Natl Acad Sci U S A.    impact factor:   0
2003;  ;[e-pub ahead of print]  304:  Sotelo C.
Timeline: Viewing the brain through the master hand of Ramon y Cajal.
Nat Rev Neurosci.    impact factor:   0
2003;  4(1): 71-7

305:  Albella B, Segovia JC, Guenechea G, Bueren JA.
Ex vivo expansion of hematopoietic stem cells.
Methods Mol Biol.    impact factor:   0
2003;  215: 363-73

306:  Ju XS, Zenke M.
Differentiation of human antigen-presenting dendritic cells from CD34+ hematopoietic stem cells in vitro.
Methods Mol Biol.    impact factor:   0
2003;  215: 399-407

307:  Broxmeyer HE, Srour EF, Hangoc G, Cooper S, Anderson SA, Bodine DM.
High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years.
Proc Natl Acad Sci U S A.    impact factor:   0
2003;  ;[e-pub ahead of print]  308:  Estey EH.
Current challenges in therapy of myelodysplastic syndromes.
Curr Opin Hematol.    impact factor:   0
2003;  10(1): 60-7

309:  Corti P, Bonanomi S, Vallinoto C, Balduzzi A, Uderzo C, Cazzaniga G, Gaipa G, Dassi M, Perseghin P, Rovelli A.
Rituximab for Immune Hemolytic Anemia following T- and B-Cell-Depleted Hematopoietic Stem Cell Transplantation.
Acta Haematol.    impact factor:   0
2003;  109(1): 43-5

310:  Gu G, Brown JR, Melton DA.
Direct lineage tracing reveals the ontogeny of pancreatic cell fates during mouse embryogenesis.
Mech Dev.    impact factor:   0
2003;  120(1): 35-43

311:  Strick-Marchand H, Weiss MC.
Embryonic liver cells and permanent lines as models for hepatocyte and bile duct cell differentiation.
Mech Dev.    impact factor:   0
2003;  120(1): 89-98

312:  Grompe M.
Pancreatic-hepatic switches in vivo.
Mech Dev.    impact factor:   0
2003;  120(1): 99-106

313:  Fausto N, Campbell JS.
The role of hepatocytes and oval cells in liver regeneration and repopulation.
Mech Dev.    impact factor:   0
2003;  120(1): 117-30

314:  Austin TW, Lagasse E.
Hepatic regeneration from hematopoietic stem cells.
Mech Dev.    impact factor:   0
2003;  120(1): 131-5

315:  Nakorn TN, Miyamoto T, Weissman IL.
Characterization of mouse clonogenic megakaryocyte progenitors.
Proc Natl Acad Sci U S A.    impact factor:   0
2003;  100(1): 205-10

316:  Erba HP.
Recent progress in the treatment of myelodysplastic syndrome in adult patients.
Curr Opin Oncol.    impact factor:   0
2003;  15(1): 1-9

317:  Colmer TD.
Aerenchyma and an Inducible Barrier to Radial Oxygen Loss Facilitate Root Aeration in Upland, Paddy and Deep-water Rice (Oryza sativa L.).
Ann Bot (Lond).    impact factor:   0
2003;  91(2): 301-9

318:  Kraal KC, Bredius RG, Lankester AC, Granzen B, Oudshoorn M, Egeler RM.
[In Process Citation]
Ned Tijdschr Geneeskd.    impact factor:   0
2002;  146(48): 2309-12

319:  Bondolfi A.
[In Process Citation]
Ther Umsch.    impact factor:   0
2002;  59(11): 561-4

320:  Wodnar-Filipowicz A.
[In Process Citation]
Ther Umsch.    impact factor:   0
2002;  59(11): 565-70

321:  Gratwohl A.
[In Process Citation]
Ther Umsch.    impact factor:   0
2002;  59(11): 571-6

322:  Surbek DV, Holzgreve W.
[In Process Citation]
Ther Umsch.    impact factor:   0
2002;  59(11): 577-82

323:  Seelmann K.
[In Process Citation]
Ther Umsch.    impact factor:   0
2002;  59(11): 583-7

324:  Jaconi M.
[In Process Citation]
Ther Umsch.    impact factor:   0
2002;  59(11): 588-95

325:  Hauck ME.
[In Process Citation]
Ther Umsch.    impact factor:   0
2002;  59(11): 596-8

326:  Zulewski H.
[In Process Citation]
Ther Umsch.    impact factor:   0
2002;  59(11): 599-602

327:  Kostka U.
[In Process Citation]
Ther Umsch.    impact factor:   0
2002;  59(11): 603-6

328:  Burgin MT, Burkli P.
[In Process Citation]
Ther Umsch.    impact factor:   0
2002;  59(11): 613-7

329:  Surbek DV, Holzgreve W.
[In Process Citation]
Ther Umsch.    impact factor:   0
2002;  59(11): 619-23

330:  Bai J, Banda N, Lee NS, Rossi J, Akkina R.
RNA-Based Anti-HIV-1 Gene Therapeutic Constructs in SCID-hu Mouse Model.
Mol Ther.    impact factor:   0
2002;  6(6): 770-82

331:  Reron A, Reron E, Strek P, Trojnar-Podlesny M.
The effect of hormonal factors on the hearing organ in women, after surgical castration. Preliminary Report.
Neuroendocrinol Lett.    impact factor:   0
2002;  23(5-6): 455-8

332:  Venukumar MR, Latha MS.
Antioxidant effect of Coscinium fenestratum in carbon tetrachloride treated rats.
Indian J Physiol Pharmacol.    impact factor:   0
2002;  46(2): 223-8

333:  [No authors listed]
[In Process Citation]
Ontogenez.    impact factor:   0
2002;  33(6): 405-20

334:  [No authors listed]
[In Process Citation]
Ontogenez.    impact factor:   0
2002;  33(6): 471-8

335:  Nakamura Y.
Architectural changes in the developing human brain based on the matrix cell theory.
Congenit Anom Kyoto.    impact factor:   0
2002;  42(3): 167-74

336:  Caton J, Prudhon JL, Aslanian T, Lifante JC, Ritz B.
[Air permeability of cement restrictors: efficacity of femoral cementing and prevention of associated cardiovascular disorders]
Rev Chir Orthop Reparatrice Appar Mot.    impact factor:   0
2002;  88(8): 767-76

337:  Giles FJ.
Gemtuzumab ozogamicin: promise and challenge in patients with acute myeloid leukemia.
Expert Rev Anticancer Ther.    impact factor:   0
2002;  2(6): 630-40

338:  [No authors listed]
[In Process Citation]
Ross Fiziol Zh Im I M Sechenova.    impact factor:   0
2002;  88(10): 1241-9

339:  [No authors listed]
[In Process Citation]
Ross Fiziol Zh Im I M Sechenova.    impact factor:   0
2002;  88(10): 1330-42

340:  Kanaji N, Ishibashi K, Uno H, Hino N.
[A patient with mantle cell lymphoma who successfully underwent auto-PBSCT in combination with in vivo purging of tumor cells using rituximab]
Gan To Kagaku Ryoho.    impact factor:   0
2002;  29(13): 2569-72

341:  Schena FP.
[Stem cells. What is their future in regenerative medicine?]
G Ital Nefrol.    impact factor:   0
2002;  19(6): 605-6

342:  Anglani F, Forino M, Gambaro G, D'Angelo A.
[In search of renal stem cells]
G Ital Nefrol.    impact factor:   0
2002;  19(6): 607-16

343:  Yamazaki R, Takayama N, Hamano Y, Mori T, Okamoto S, Ikeda Y.
[Localized recurrence of acute lymphoblastic leukemia-L3 in the tonsil after 3-years' remission]
Rinsho Ketsueki.    impact factor:   0
2002;  43(11): 1004-8

344:  Nagasawa E, Abe Y, Matsushima T, Choi I, Tachikawa Y, Nishimura J, Inaba S, Nawata H, Muta K.
[Persistent T-cell mixed chimerism in a case of malignant lymphoma after nonmyeloablative allogeneic peripheral blood stem cell transplantation]
Rinsho Ketsueki.    impact factor:   0
2002;  43(11): 1014-9

345:  Chen Y, Huang X, Xu L, Liu D, Zhang Y, Ren H, Guo N, Lu D.
A pilot study of G-CSF mobilized allogeneic bone marrow cells plus peripheral blood stem cells transplantation for malignant hematological diseases.
Zhonghua Yi Xue Za Zhi.    impact factor:   0
2002;  82(19): 1306-9

346:  He Z, Huang S, Li Y, Zhang Q.
Human embryonic stem cell lines preliminarily established in China.
Zhonghua Yi Xue Za Zhi.    impact factor:   0
2002;  82(19): 1314-8

347:  Jia Y, Yang Y, Zhou Y, Song Y, Liu L, Song J, Wang X, Zhong L, Yu X.
Differentiation of rat bone marrow stromal cells into neuron induced by baicalin.
Zhonghua Yi Xue Za Zhi.    impact factor:   0
2002;  82(19): 1337-41

348:  Lewis ID.
Clinical and experimental uses of umbilical cord blood.
Intern Med J.    impact factor:   0
2002;  32(12): 601-9

349:  Nabika S, Oki S, Migita K, Isobe N, Okazaki T, Watanabe Y, Kurisu K, Hayashi Y.
Dissecting basilar artery aneurysm growing during long-term follow up--case report.
Neurol Med Chir (Tokyo).    impact factor:   0
2002;  42(12): 560-4

350:  Colvin GA, Lambert JF, Carlson JE, McAuliffe CI, Abedi M, Quesenberry PJ.
In Vitro Cell Dev Biol Anim.    impact factor:   0
2002;  38(6): 343-351

351:  Ookura T, Kawamoto K, Tsuzaki H, Mikami Y, Ito Y, Oh SH, Hino A.
In Vitro Cell Dev Biol Anim.    impact factor:   0
2002;  38(6): 365-372

352:  Spielmann H, Liebsch M.
Validation successes: chemicals.
Altern Lab Anim.    impact factor:   0
2002;  30 Suppl 2: 33-40

353:  Bremer S.
Development of a Testing Strategy for Detecting Embryotoxic Hazards of Chemicals In Vitro by using Embryonic Stem Cell Models.
Altern Lab Anim.    impact factor:   0
2002;  30 Suppl 2: 107-9

354:  Gribaldo L.
Haematotoxicology: scientific basis and regulatory aspects.
Altern Lab Anim.    impact factor:   0
2002;  30 Suppl 2: 111-3

355:  Poreddy V, DeLeve LD.
Hepatic circulatory diseases associated with chronic myeloid disorders.
Clin Liver Dis.    impact factor:   0
2002;  6(4): 909-31

356:  Chung C, Buchman AL.
Postoperative jaundice and total parenteral nutrition-associated hepatic dysfunction.
Clin Liver Dis.    impact factor:   0
2002;  6(4): 1067-84

357:  Emerich DF.
Islet transplantation for diabetes: current status and future prospects.
Expert Opin Biol Ther.    impact factor:   0
2002;  2(8): 793-803

358:  Jain KK.
Ethical and regulatory aspects of embryonic stem cell research.
Expert Opin Biol Ther.    impact factor:   0
2002;  2(8): 819-26

359:  Marini FC, Shayakhmetov D, Gharwan H, Lieber A, Andreeff M.
Advances in gene transfer into haematopoietic stem cells by adenoviral vectors.
Expert Opin Biol Ther.    impact factor:   0
2002;  2(8): 847-56

360:  Willis F, Pettengell R.
Expert Opin Biol Ther.    impact factor:   0
2002;  2(8): 985-92

361:  Kombos T, Suess O, Brock M.
Cost Analysis of Intraoperative Neurophysiological Monitoring (IOM).
Zentralbl Neurochir.    impact factor:   0
2002;  63(4): 141-145

362:  Tateno C, Yoshizato K.
[Liver stem cells and regenerative medicine]
Nippon Shokakibyo Gakkai Zasshi.    impact factor:   0
2002;  99(12): 1428-35

363:  Takaki S.
[Lnk, an adaptor protein regulate production of B cells and hematopoietic stem cells]
Tanpakushitsu Kakusan Koso.    impact factor:   0
2002;  47(16 Suppl): 2188-93

364:  Koster MI, Huntzinger KA, Roop DR.
Epidermal differentiation: transgenic/knockout mouse models reveal genes involved in stem cell fate decisions and commitment to differentiation.
J Investig Dermatol Symp Proc.    impact factor:   0
2002;  7(1): 41-5

365:  Richmond LJ, Alcorn MJ, Pearson C, Cameron G, Thomas T, Eaves CJ, Eaves AC, Holyoake TL.
CML leukapheresis products can be enriched for CD34(+) cells and simultaneously depleted of CD15(+) cells using a simple Ab cocktail.
Cytotherapy.    impact factor:   0
2002;  4(5): 407-13

366:  Douek DC.
The contribution of the thymus to immune reconstitution after hematopoietic stem-cell transplantation.
Cytotherapy.    impact factor:   0
2002;  4(5): 425-6

367:  Mackall CL.
Enhancing immune reconstitution after stem cell transplants with cytokines.
Cytotherapy.    impact factor:   0
2002;  4(5): 427-8

368:  O'Reilly RJ.
Immunologic aspects of hematopoietic stem-cell transplantation.
Cytotherapy.    impact factor:   0
2002;  4(5): 431-2

369:  Heslop HE, Bollard CM, Gottschalk S, Kuehnle I, Huls MH, Gee AP, Brenner MK, Rooney CM.
Immune therapy for EBV infections after hemopoietic stem-cell transplant.
Cytotherapy.    impact factor:   0
2002;  4(5): 433-4

370:  Farag SS, Fehniger T, Ruggeri L, Velardi A, Caligiuri MA.
Natural killer cells: biology and application in stem-cell transplantation.
Cytotherapy.    impact factor:   0
2002;  4(5): 445-6

371:  Ou L, Liu H, Wang D, Luo Y, Ma L, Yuan Z.
[The study of calcification of autogenous bone marrow stem cell transplantation on alveolar bone defect in dogs]
Zhonghua Kou Qiang Yi Xue Za Zhi.    impact factor:   0
2002;  37(2): 132-4

372:  Evans MI, Harrison MR, Flake AW, Johnson MP.
Fetal therapy.
Best Pract Res Clin Obstet Gynaecol.    impact factor:   0
2002;  16(5): 671-83

373:  Hirasawa M, Ikebe S, Komatsuzaki Y, Takanashi M, Mori H, Urabe T, Mizuno Y.
[A 52-year-old woman with dyskinesia, epilepsy and gait disturbance]
No To Shinkei.    impact factor:   0
2002;  54(10): 919-27

374:  Yoder MC.
Embryonic hematopoiesis in mice and humans.
Acta Paediatr Suppl.    impact factor:   0
2002;  91(438): 5-8

375:  White C, Chen Z, Raetz E, Pulsipher M, Spangrude GJ, Slayton WB.
Using fluorescence-activated cell sorting followed by fluorescence in situ hybridization to study lineage relationships: the 8;21 translocation is present in neutrophils but not monocytes in a patient with severe congenital neutropenia and a granulocyte colony-stimulating factor-responsive clonal abnormality.
Acta Paediatr Suppl.    impact factor:   0
2002;  91(438): 120-3

376:  Murdoch A.
Human embryonic stem cells: an introduction.
Hum Fertil (Camb).    impact factor:   0
2002;  5(4): 203-5

377:  Stroncek D, Harvath L, Barrett J.
National Heart, Lung, and Blood Institute of the National Institutes of Health forum on immune reconstitution and cellular therapy following hematopoietic stem-cell transplantation.
Cytotherapy.    impact factor:   0
2002;  4(5): 415-8

378:  Fraser LR.
ART: boon or bane?
Nat Cell Biol.    impact factor:   0
2002;  4 Suppl: s10-3

379:  Schatten GP.
Safeguarding ART.
Nat Cell Biol.    impact factor:   0
2002;  4 Suppl: s19-22

380:  Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochi T, Inoue J, Wagner EF, Mak TW, Kodama T, Taniguchi T.
Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts.
Dev Cell.    impact factor:   0
2002;  3(6): 889-901

381:  Gervers M, Nolte I, Alt F, Hauschild G, Meyer-Lindenberg A, Fehr M.
[In Process Citation]
Berl Munch Tierarztl Wochenschr.    impact factor:   0
2002;  115(11-12): 412-9

382:  Fu J, Liu Y, Zhang X.
CD(40) ligandization promotes IL-6 and Flt3 ligand production of bone marrow stromal cells.
Zhonghua Xue Ye Xue Za Zhi.    impact factor:   0
2002;  23(11): 585-7

383:  Huang X, Shi H, Guo N, Lu D.
Allogeneic bone marrow transplantation for the treatment of Bruton disease.
Zhonghua Xue Ye Xue Za Zhi.    impact factor:   0
2002;  23(10): 528-30

384:  Liu D, Punzel M, Ho A.
Initial division behavior of cord blood hematopoietic stem cells depends on microenvironment.
Zhonghua Xue Ye Xue Za Zhi.    impact factor:   0
2002;  23(10): 534-537

385:  Yoo KH, Sohn WY, Sung KW, Jung HL, Koo HH, Oh SY, Kang SW.
Chemoreduction followed by local therapy and adjuvant chemotherapy for advanced intraocular retinoblastoma: a pilot study in a single center.
J Korean Med Sci.    impact factor:   0
2002;  17(6): 817-22

386:  Zhou A, Shi Y, Feng F, Lu S, He X, Han X.
Contamination with minimal residual disease in autologous peripheral stem cell collected from Non-Hodgkin's lymphoma patients treated with high-dose therapy.
Zhonghua Zhong Liu Za Zhi.    impact factor:   0
2002;  24(5): 467-70

387:  Tian Y, Guo Z, Zhu M.
Radiation encephalopathy in nasopharyngeal carcinoma patients in mainland China: a systematic evaluation.
Zhonghua Zhong Liu Za Zhi.    impact factor:   0
2002;  24(5): 471-4

388:  Tang X, Wu D, Xue Y, Zhu M, Lu D, Ruan C.
The morphological, immunophenotypical and cytogenetic characteristics study of blast crisis in chronic myeloid leukemia.
Zhonghua Nei Ke Za Zhi.    impact factor:   0
2002;  41(10): 685-7

389:  Sieber OM, Heinimann K, Gorman P, Lamlum H, Crabtree M, Simpson CA, Davies D, Neale K, Hodgson SV, Roylance RR, Phillips RK, Bodmer WF, Tomlinson IP.
Analysis of chromosomal instability in human colorectal adenomas with two mutational hits at APC.
Proc Natl Acad Sci U S A.    impact factor:   0
2002;  99(26): 16910-5

390:  Tseng JF, Mulligan RC.
Gene therapy for pancreatic cancer.
Surg Oncol Clin N Am.    impact factor:   0
2002;  11(3): 537-69

391:  Terando A, Chang AE.
Applications of gene transfer to cellular immunotherapy.
Surg Oncol Clin N Am.    impact factor:   0
2002;  11(3): 621-43

392:  Tang J, Wang X, Qin J, Pan L, Wu J, Feng J, Zhao X, Zheng X, Zhu J, Dai A.
Preoperative high-dose chemotherapy with peripheral blood stem cell support in breast cancer: report of 3 cases.
Zhonghua Wai Ke Za Zhi.    impact factor:   0
2002;  40(11): 803-6

393:  Song Z, Gu K.
Transdifferentiating of adult human pancreatic stem cells into islet cells.
Zhonghua Wai Ke Za Zhi.    impact factor:   0
2002;  40(11): 807-10

394:  Yang L, Hui G, Bao D, Jiang L, Fei J, Guo L.
Long-term culture and differentiation of neural stem cells of embryonic mice.
Zhonghua Wai Ke Za Zhi.    impact factor:   0
2002;  40(10): 783-5

395:  Agbonon A, Eklu-Gadegbeku K, Aklikokou K, Essien K, Akpagana K, Gbeassor M.
The effect of Mangifera indica stem bark and Pluchea ovalis roots on tracheal smooth muscle in vitro.
Fitoterapia.    impact factor:   0
2002;  73(7-8): 619-22

396:  Nandha Kumar R, Vishwanathan H, Suresh T, Mohan PS.
Antibacterial activity of Mappia foetida leaves and stem.
Fitoterapia.    impact factor:   0
2002;  73(7-8): 734-6

397:  Khan MR, Kihara M, Omoloso AD.
Antimicrobial activity of Terminalia complanata and Flacourtia zippelii.
Fitoterapia.    impact factor:   0
2002;  73(7-8): 737-40

398:  Khan MR, Kihara M, Omoloso AD.
Antimicrobial activity of Calophyllum soulattri.
Fitoterapia.    impact factor:   0
2002;  73(7-8): 741-3

399:  Khan MR, Kihara M, Omoloso AD.
Antimicrobial activity of Michelia champaca.
Fitoterapia.    impact factor:   0
2002;  73(7-8): 744-8

400:  Villette S, Kyle JA, Brown KM, Pickard K, Milne JS, Nicol F, Arthur JR, Hesketh JE.
A novel single nucleotide polymorphism in the 3' untranslated region of human glutathione peroxidase 4 influences lipoxygenase metabolism.
Blood Cells Mol Dis.    impact factor:   0
2002;  29(2): 174-8

401:  Prost S, LeDiscorde M, Haddad R, Gluckman JC, Canque B, Kirszenbaum M.
Characterization of a novel hematopoietic marker expressed from early embryonic hematopoietic stem cells to adult mature lineages.
Blood Cells Mol Dis.    impact factor:   0
2002;  29(2): 236-48

402:  Endo H, Kumabe T, Kon H, Yoshimoto T, Nakasato Y.
[A case of primary cerebellar glioblastoma in childhood]
No Shinkei Geka.    impact factor:   0
2002;  30(12): 1325-9

403:  Oishi K, Kawakita E, Uchida MK.
[Differentiation of neural stem cells into blood vessel cells and their modulators]
Nippon Yakurigaku Zasshi.    impact factor:   0
2002;  120(1): 51P-53P

404:  Nakatsuji N.
[Embryonic stem cell lines for regenerative therapy and pharmaceutical research]
Nippon Yakurigaku Zasshi.    impact factor:   0
2002;  120(5): 295-302

405:  Jacob F.
[In Process Citation]
C R Biol.    impact factor:   0
2002;  325(10): 999-1002

406:  Evans M, Hunter S.
Source and nature of embryonic stem cells.
C R Biol.    impact factor:   0
2002;  325(10): 1003-7

407:  McLaren A.
Human embryonic stem cell lines: socio-legal concerns and therapeutic promise.
C R Biol.    impact factor:   0
2002;  325(10): 1009-12

408:  Dieterlen-Lievre F, Pardanaud L, Bollerot K, Jaffredo T.
Hemangioblasts and hemopoietic stem cells during ontogeny.
C R Biol.    impact factor:   0
2002;  325(10): 1013-20

409:  Peault B, Oberlin E, Tavian M.
Emergence of hematopoietic stem cells in the human embryo.
C R Biol.    impact factor:   0
2002;  325(10): 1021-6

410:  Fukuda K.
Reprogramming of bone marrow mesenchymal stem cells into cardiomyocytes.
C R Biol.    impact factor:   0
2002;  325(10): 1027-38

411:  Theise ND.
New principles of cell plasticity.
C R Biol.    impact factor:   0
2002;  325(10): 1039-43

412:  Westphal H.
International stem cell research considerations.
C R Biol.    impact factor:   0
2002;  325(10): 1045-8

413:  Lachmann PJ.
Stem cell therapy: medical advance or moral challenge?
C R Biol.    impact factor:   0
2002;  325(10): 1049-51

414:  Cavazzana-Calvo M, Andre-Schmutz I, Lagresle C, Fischer A.
Medical perspectives of adults and embryonic stem cells.
C R Biol.    impact factor:   0
2002;  325(10): 1053-8

415:  Pellerin D.
[In Process Citation]
C R Biol.    impact factor:   0
2002;  325(10): 1059-63

416:  Tubiana M.
[In Process Citation]
C R Biol.    impact factor:   0
2002;  325(10): 1065-71

417:  Marechal M.
[In Process Citation]
Ned Tijdschr Tandheelkd.    impact factor:   0
2002;  109(11): 439-43

418:  Hakkinen L, Koivisto L, Larjava H.
An improved method for culture of epidermal keratinocytes from newborn mouse skin.
Methods Cell Sci.    impact factor:   0
2001;  23(4): 189-96

419:  Li AL.
[Effect of gradient magnetic field on growth of stem pearls of Dioscorea opposita during seedling stage]
Zhongguo Zhong Yao Za Zhi.    impact factor:   0
2000;  25(6): 341-3

420:  Li JS, Zhu ZY, Cai SQ.
[A survey on botanical origins of drug xue lianhua produced in China]
Zhongguo Zhong Yao Za Zhi.    impact factor:   0
2000;  25(8): 461-5

421:  Zhong MZ, Chen FP, Qi ZH.
[Treatment of lymphoma and malignant melanoma with autologous peripheral blood stem cell transplantation]
Hunan Yi Ke Da Xue Xue Bao.    impact factor:   0
2000;  25(6): 566, 569

422:  Tang K, Chen R, Cal R, Zhou J, Huang J, Long W, Mo Z.
[The relationship of brainstem auditory evoked potential to cerebral blood flow volume in with vertebrobasilar transient ischemic vertigo]
Hua Xi Yi Ke Da Xue Xue Bao.    impact factor:   0
2000;  31(1): 80-1, 85

423:  Chen Y, Qin LP, Zheng HC, Zhang ZH.
[Resources distribution and pharamacognostic identification of Centella asiatica (L.) urban produced in China]
Zhongguo Zhong Yao Za Zhi.    impact factor:   0
2000;  25(4): 199-202


Responsed in 656 milliseconds.

Webpage designed by Dr. Xueliang Fang, last updated on 3/10/2005